{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:06:29Z","timestamp":1787583989950,"version":"build-2736575974"},"reference-count":335,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T00:00:00Z","timestamp":1641254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T00:00:00Z","timestamp":1641254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"deutsche forschungsgemeinschaft","doi-asserted-by":"publisher","award":["JA 1823\/3-1"],"award-info":[{"award-number":["JA 1823\/3-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"deutsche forschungsgemeinschaft","doi-asserted-by":"publisher","award":["2-1"],"award-info":[{"award-number":["2-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"deutsche forschungsgemeinschaft","doi-asserted-by":"crossref","award":["SE 697\/6-1"],"award-info":[{"award-number":["SE 697\/6-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"deutsche forschungsgemeinschaft","doi-asserted-by":"crossref","award":["4-2"],"award-info":[{"award-number":["4-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"deutsche forschungsgemeinschaft","doi-asserted-by":"crossref","award":["5-2"],"award-info":[{"award-number":["5-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"deutsche forschungsgemeinschaft","doi-asserted-by":"crossref","award":["7-1"],"award-info":[{"award-number":["7-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"name":"picoquant"},{"name":"bmbf","award":["CalsER Network"],"award-info":[{"award-number":["CalsER Network"]}]},{"DOI":"10.13039\/100007721","name":"cure sma","doi-asserted-by":"crossref","award":["JAB1920"],"award-info":[{"award-number":["JAB1920"]}],"id":[{"id":"10.13039\/100007721","id-type":"DOI","asserted-by":"crossref"}]},{"name":"lilly schilling stiftung"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol. Res. Pract."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Major efforts have been made in the last decade to develop and improve therapies for proximal spinal muscular atrophy (SMA). The introduction of Nusinersen\/Spinraza\u2122 as an antisense oligonucleotide therapy, Onasemnogene abeparvovec\/Zolgensma\u2122 as an AAV9-based gene therapy and Risdiplam\/Evrysdi\u2122 as a small molecule modifier of pre-mRNA splicing have set new standards for interference with neurodegeneration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main body<\/jats:title>\n                    <jats:p>Therapies for SMA are designed to interfere with the cellular basis of the disease by modifying pre-mRNA splicing and enhancing expression of the Survival Motor Neuron (SMN) protein, which is only expressed at low levels in this disorder. The corresponding strategies also can be applied to other disease mechanisms caused by loss of function or toxic gain of function mutations. The development of therapies for SMA was based on the use of cell culture systems and mouse models, as well as innovative clinical trials that included readouts that had originally been introduced and optimized in preclinical studies. This is summarized in the first part of this review. The second part discusses current developments and perspectives for amyotrophic lateral sclerosis, muscular dystrophies, Parkinson's and Alzheimer's disease, as well as the obstacles that need to be overcome to introduce RNA-based therapies and gene therapies for these disorders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>RNA-based therapies offer chances for therapy development of complex neurodegenerative disorders such as amyotrophic lateral sclerosis, muscular dystrophies, Parkinson\u2019s and Alzheimer\u2019s disease. The experiences made with these new drugs for SMA, and also the experiences in AAV gene therapies could help to broaden the spectrum of current approaches to interfere with pathophysiological mechanisms in neurodegeneration.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s42466-021-00162-9","type":"journal-article","created":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T07:02:54Z","timestamp":1641279774000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Therapy development for spinal muscular atrophy: perspectives for muscular dystrophies and neurodegenerative disorders"],"prefix":"10.1186","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4517-3760","authenticated-orcid":false,"given":"Sibylle","family":"Jablonka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Hennlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sendtner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,4]]},"reference":[{"issue":"5","key":"162_CR1","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1089\/nat.2017.0682","volume":"27","author":"A Aartsma-Rus","year":"2017","unstructured":"Aartsma-Rus, A., Straub, V., Hemmings, R., Haas, M., Schlosser-Weber, G., Stoyanova-Beninska, V., Mercuri, E., Muntoni, F., Sepodes, B., Vroom, E., & Balabanov, P. (2017). Development of exon skipping therapies for duchenne muscular dystrophy: A critical review and a perspective on the outstanding issues [Review]. Nucleic Acid Therapeutics, 27(5), 251\u2013259. https:\/\/doi.org\/10.1089\/nat.2017.0682","journal-title":"Nucleic Acid Therapeutics"},{"issue":"4","key":"162_CR2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/ng0493-283","volume":"3","author":"AH Ahn","year":"1993","unstructured":"Ahn, A. H., & Kunkel, L. M. (1993). The structural and functional diversity of dystrophin. Nature Genetics, 3(4), 283\u2013291. https:\/\/doi.org\/10.1038\/ng0493-283","journal-title":"Nature Genetics"},{"key":"162_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.pediatrneurol.2019.06.007","volume":"100","author":"SA Al-Zaidy","year":"2019","unstructured":"Al-Zaidy, S. A., & Mendell, J. R. (2019). From clinical trials to clinical practice: Practical considerations for gene replacement therapy in SMA Type 1. Pediatric Neurology, 100, 3\u201311. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2019.06.007","journal-title":"Pediatric Neurology"},{"issue":"3","key":"162_CR4","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.neuron.2013.12.018","volume":"81","author":"NH Alami","year":"2014","unstructured":"Alami, N. H., Smith, R. B., Carrasco, M. A., Williams, L. A., Winborn, C. S., Han, S. S. W., Kiskinis, E., Winborn, B., Freibaum, B. D., Kanagaraj, A., Clare, A. J., Badders, N. M., Bilican, B., Chaum, E., Chandran, S., Shaw, C. E., Eggan, K. C., Maniatis, T., & Taylor, J. P. (2014). Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov\u2019t]. Neuron, 81(3), 536\u2013543. https:\/\/doi.org\/10.1016\/j.neuron.2013.12.018","journal-title":"Neuron"},{"key":"162_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.omtm.2018.01.007","volume":"9","author":"A Alrafiah","year":"2018","unstructured":"Alrafiah, A., Karyka, E., Coldicott, I., Iremonger, K., Lewis, K. E., Ning, K., & Azzouz, M. (2018). Plastin 3 promotes motor neuron axonal growth and extends survival in a mouse model of spinal muscular atrophy. Molecular Therapy-Methods & Clinical Development, 9, 81\u201389. https:\/\/doi.org\/10.1016\/j.omtm.2018.01.007","journal-title":"Molecular Therapy-Methods & Clinical Development"},{"issue":"Pt 4","key":"162_CR6","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1093\/brain\/119.4.1153","volume":"119","author":"PM Andersen","year":"1996","unstructured":"Andersen, P. M., Forsgren, L., Binzer, M., Nilsson, P., Ala-Hurula, V., Keranen, M. L., Bergmark, L., Saarinen, A., Haltia, T., Tarvainen, I., Kinnunen, E., Udd, B., & Marklund, S. L. (1996). Autosomal recessive adult-onset amyotrophic lateral sclerosis associated with homozygosity for Asp90Ala CuZn-superoxide dismutase mutation. A clinical and genealogical study of 36 patients [Research Support, Non-U.S. Gov\u2019t]. Brain, 119(Pt 4), 1153\u20131172. https:\/\/doi.org\/10.1093\/brain\/119.4.1153","journal-title":"Brain"},{"key":"162_CR7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/ng0595-61","volume":"10","author":"PM Andersen","year":"1995","unstructured":"Andersen, P. M., Nilsson, P., Ala Hurula, V., Keranen, M. L., Tarvainen, I., Haltia, T., Nilsson, L., Binzer, M., Forsgren, L., & Marklund, S. L. (1995). Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase. Nature Genetics, 10, 61\u201366.","journal-title":"Nature Genetics"},{"issue":"2","key":"162_CR8","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1046\/j.1471-4159.1998.70020715.x","volume":"70","author":"PM Andersen","year":"1998","unstructured":"Andersen, P. M., Nilsson, P., Forsgren, L., & Marklund, S. L. (1998). CuZn-superoxide dismutase, extracellular superoxide dismutase, and glutathione peroxidase in blood from individuals homozygous for Asp90Ala CuZu-superoxide dismutase mutation [Research Support, Non-U.S. Gov\u2019t]. Journal of Neurochemistry, 70(2), 715\u2013720. https:\/\/doi.org\/10.1046\/j.1471-4159.1998.70020715.x","journal-title":"Journal of Neurochemistry"},{"issue":"5","key":"162_CR9","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/mus.26017","volume":"57","author":"JA Andrews","year":"2018","unstructured":"Andrews, J. A., Miller, T. M., Vijayakumar, V., Stoltz, R., James, J. K., Meng, L., Wolff, A. A., & Malik, F. I. (2018). CK-2127107 amplifies skeletal muscle response to nerve activation in humans [Clinical Trial, Phase I Randomized Controlled Trial Research Support, Non-U.S. Gov\u2019t]. Muscle and Nerve, 57(5), 729\u2013734. https:\/\/doi.org\/10.1002\/mus.26017","journal-title":"Muscle and Nerve"},{"issue":"14","key":"162_CR10","doi-asserted-by":"publisher","first-page":"e1312","DOI":"10.1212\/WNL.0000000000006281","volume":"91","author":"K Aragon-Gawinska","year":"2018","unstructured":"Aragon-Gawinska, K., Seferian, A. M., Daron, A., Gargaun, E., Vuillerot, C., Cances, C., Ropars, J., Chouchane, M., Cuppen, I., Hughes, I., Illingworth, M., Marini-Bettolo, C., Rambaud, J., Taytard, J., Annoussamy, M., Scoto, M., Gidaro, T., & Servais, L. (2018). Nusinersen in patients older than 7 months with spinal muscular atrophy type 1: A cohort study [Clinical Trial Research Support, Non-U.S. Gov\u2019t]. Neurology, 91(14), e1312\u2013e1318. https:\/\/doi.org\/10.1212\/WNL.0000000000006281","journal-title":"Neurology"},{"key":"162_CR11","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1523\/JNEUROSCI.10-11-03507.1990","volume":"10","author":"Y Arakawa","year":"1990","unstructured":"Arakawa, Y., Sendtner, M., & Thoenen, H. (1990). Survival effect of ciliary neurotrophic factor (CNTF) on chick embryonic motoneurons in culture: Comparison with other neurotrophic factors and cytokines. Journal of Neuroscience, 10, 3507\u20133515.","journal-title":"Journal of Neuroscience"},{"issue":"10","key":"162_CR12","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/labinvest.3700163","volume":"84","author":"AS Arnold","year":"2004","unstructured":"Arnold, A. S., Gueye, M., Guettier-Sigrist, S., Courdier-Fruh, I., Coupin, G., Poindron, P., & Gies, J. P. (2004). Reduced expression of nicotinic AChRs in myotubes from spinal muscular atrophy I patients [Research Support, Non-U.S. Gov\u2019t]. Laboratory Investigation, 84(10), 1271\u20131278. https:\/\/doi.org\/10.1038\/labinvest.3700163","journal-title":"Laboratory Investigation"},{"key":"162_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/d41591-019-00021-w","author":"C Arnold","year":"2019","unstructured":"Arnold, C. (2019). Custom therapies pose huge financial burdens. Nature Medicine. https:\/\/doi.org\/10.1038\/d41591-019-00021-w","journal-title":"Nature Medicine"},{"key":"162_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/d41591-019-00013-w","author":"C Arnold","year":"2019","unstructured":"Arnold, C. (2019). Tailored treatment for ALS poised to move ahead. Nature Medicine. https:\/\/doi.org\/10.1038\/d41591-019-00013-w","journal-title":"Nature Medicine"},{"issue":"4","key":"162_CR15","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.neuron.2013.02.004","volume":"77","author":"PE Ash","year":"2013","unstructured":"Ash, P. E., Bieniek, K. F., Gendron, T. F., Caulfield, T., Lin, W. L., Dejesus-Hernandez, M., van Blitterswijk, M. M., Jansen-West, K., Paul, J. W., 3rd., Rademakers, R., Boylan, K. B., Dickson, D. W., & Petrucelli, L. (2013). Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD\/ALS [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov\u2019t]. Neuron, 77(4), 639\u2013646. https:\/\/doi.org\/10.1016\/j.neuron.2013.02.004","journal-title":"Neuron"},{"issue":"1","key":"162_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biomedicines6010001","volume":"6","author":"T Aslesh","year":"2018","unstructured":"Aslesh, T., Maruyama, R., & Yokota, T. (2018). Skipping multiple exons to treat DMD-promises and challenges [review]. Biomedicines, 6(1), 1. https:\/\/doi.org\/10.3390\/biomedicines6010001","journal-title":"Biomedicines"},{"issue":"12","key":"162_CR17","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1172\/JCI22922","volume":"114","author":"M Azzouz","year":"2004","unstructured":"Azzouz, M., Le, T., Ralph, G. S., Walmsley, L., Monani, U. R., Lee, D. C., Wilkes, F., Mitrophanous, K. A., Kingsman, S. M., Burghes, A. H., & Mazarakis, N. D. (2004). Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy. The Journal of Clinical Investigation, 114(12), 1726\u20131731. https:\/\/doi.org\/10.1172\/JCI22922","journal-title":"The Journal of Clinical Investigation"},{"issue":"12","key":"162_CR18","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1093\/hmg\/ddw105","volume":"25","author":"KR Baldwin","year":"2016","unstructured":"Baldwin, K. R., Godena, V. K., Hewitt, V. L., & Whitworth, A. J. (2016). Axonal transport defects are a common phenotype in Drosophila models of ALS. Human Molecular Genetics, 25(12), 2378\u20132392. https:\/\/doi.org\/10.1093\/hmg\/ddw105","journal-title":"Human Molecular Genetics"},{"issue":"10","key":"162_CR19","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1056\/NEJMoa2009965","volume":"384","author":"G Baranello","year":"2021","unstructured":"Baranello, G., Darras, B. T., Day, J. W., Deconinck, N., Klein, A., Masson, R., Mercuri, E., Rose, K., El-Khairi, M., Gerber, M., Gorni, K., Khwaja, O., Kletzl, H., Scalco, R. S., Seabrook, T., Fontoura, P., Servais, L., & Group, F. W. (2021). Risdiplam in Type 1 Spinal Muscular Atrophy. New England Journal of Medicine, 384(10), 915\u2013923. https:\/\/doi.org\/10.1056\/NEJMoa2009965","journal-title":"New England Journal of Medicine"},{"issue":"11","key":"162_CR20","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1093\/hmg\/6.11.1961","volume":"6","author":"G Battaglia","year":"1997","unstructured":"Battaglia, G., Princivalle, A., Forti, F., Lizier, C., & Zeviani, M. (1997). Expression of the SMN gene, the spinal muscular atrophy determining gene, in the mammalian central nervous system. Human Molecular Genetics, 6(11), 1961\u20131971.","journal-title":"Human Molecular Genetics"},{"issue":"7650","key":"162_CR21","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nature22038","volume":"544","author":"LA Becker","year":"2017","unstructured":"Becker, L. A., Huang, B., Bieri, G., Ma, R., Knowles, D. A., Jafar-Nejad, P., Messing, J., Kim, H. J., Soriano, A., Auburger, G., Pulst, S. M., Taylor, J. P., Rigo, F., & Gitler, A. D. (2017). Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice. Nature, 544(7650), 367\u2013371. https:\/\/doi.org\/10.1038\/nature22038","journal-title":"Nature"},{"issue":"3","key":"162_CR22","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00441-020-03236-3","volume":"381","author":"MT Berciano","year":"2020","unstructured":"Berciano, M. T., Castillo-Iglesias, M. S., Val-Bernal, J. F., Lafarga, V., Rodriguez-Rey, J. C., Lafarga, M., & Tapia, O. (2020). Mislocalization of SMN from the I-band and M-band in human skeletal myofibers in spinal muscular atrophy associates with primary structural alterations of the sarcomere. Cell and Tissue Research, 381(3), 461\u2013478. https:\/\/doi.org\/10.1007\/s00441-020-03236-3","journal-title":"Cell and Tissue Research"},{"issue":"3","key":"162_CR23","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/ajmg.1320330309","volume":"33","author":"E Bertini","year":"1989","unstructured":"Bertini, E., Gadisseux, J. L., Palmieri, G., Ricci, E., Di, C. M., Ferriere, G., & Lyon, G. (1989). Distal infantile spinal muscular atrophy associated with paralysis of the diaphragm: a variant of infantile spinal muscular atrophy. American Journal of Medical Genetics, 33(3), 328\u2013335.","journal-title":"American Journal of Medical Genetics"},{"issue":"4","key":"162_CR24","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/humu.22758","volume":"36","author":"CL Bladen","year":"2015","unstructured":"Bladen, C. L., Salgado, D., Monges, S., Foncuberta, M. E., Kekou, K., Kosma, K., Dawkins, H., Lamont, L., Roy, A. J., Chamova, T., Guergueltcheva, V., Chan, S., Korngut, L., Campbell, C., Dai, Y., Wang, J., Barisic, N., Brabec, P., Lahdetie, J., \u2026 Lochmuller, H. (2015). The TREAT-NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations [Research Support, Non-U.S. Gov\u2019t]. Human Mutatation, 36(4), 395\u2013402. https:\/\/doi.org\/10.1002\/humu.22758","journal-title":"Human Mutatation"},{"issue":"2","key":"162_CR25","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3390\/ph3020345","volume":"3","author":"T Bordet","year":"2010","unstructured":"Bordet, T., Berna, P., Abitbol, J. L., & Pruss, R. M. (2010). Olesoxime (TRO19622): A novel mitochondrial-targeted neuroprotective compound. Pharmaceuticals (Basel), 3(2), 345\u2013368. https:\/\/doi.org\/10.3390\/ph3020345","journal-title":"Pharmaceuticals (Basel)"},{"issue":"9","key":"162_CR26","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1093\/hmg\/ddr067","volume":"20","author":"M Bosch-Marce","year":"2011","unstructured":"Bosch-Marce, M., Wee, C. D., Martinez, T. L., Lipkes, C. E., Choe, D. W., Kong, L., Van Meerbeke, J. P., Musaro, A., & Sumner, C. J. (2011). Increased IGF-1 in muscle modulates the phenotype of severe SMA mice. Human Molecular Genetics, 20(9), 1844\u20131853.","journal-title":"Human Molecular Genetics"},{"issue":"6","key":"162_CR27","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1089\/hum.2009.182","volume":"21","author":"S Boutin","year":"2010","unstructured":"Boutin, S., Monteilhet, V., Veron, P., Leborgne, C., Benveniste, O., Montus, M. F., & Masurier, C. (2010). Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: Implications for gene therapy using AAV vectors. Human Gene Therapy, 21(6), 704\u2013712. https:\/\/doi.org\/10.1089\/hum.2009.182","journal-title":"Human Gene Therapy"},{"issue":"8","key":"162_CR28","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1242\/dmm.030148","volume":"10","author":"M Bowerman","year":"2017","unstructured":"Bowerman, M., Becker, C. G., Yanez-Munoz, R. J., Ning, K., Wood, M. J. A., Gillingwater, T. H., Talbot, K., & Consortium, U. S. R. (2017). Therapeutic strategies for spinal muscular atrophy: SMN and beyond [Review Research Support, Non-U.S. Gov\u2019t]. Disease Models & Mechanisms, 10(8), 943\u2013954. https:\/\/doi.org\/10.1242\/dmm.030148","journal-title":"Disease Models & Mechanisms"},{"issue":"11 Suppl 3","key":"162_CR29","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.1097\/PHM.0000000000000138","volume":"93","author":"R Braun","year":"2014","unstructured":"Braun, R., Wang, Z., Mack, D. L., & Childers, M. K. (2014). Gene therapy for inherited muscle diseases: Where genetics meets rehabilitation medicine [Review]. American Journal of Physical Medicine and Rehabilitation, 93(11 Suppl 3), S97-107. https:\/\/doi.org\/10.1097\/PHM.0000000000000138","journal-title":"American Journal of Physical Medicine and Rehabilitation"},{"issue":"8951","key":"162_CR30","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/s0140-6736(95)90869-2","volume":"345","author":"S Braun","year":"1995","unstructured":"Braun, S., Croizat, B., Lagrange, M. C., Warter, J. M., & Poindron, P. (1995). Constitutive muscular abnormalities in culture in spinal muscular atrophy. Lancet, 345(8951), 694\u2013695. https:\/\/doi.org\/10.1016\/s0140-6736(95)90869-2","journal-title":"Lancet"},{"issue":"18","key":"162_CR31","doi-asserted-by":"publisher","first-page":"4745","DOI":"10.1093\/hmg\/ddu189","volume":"23","author":"KV Bricceno","year":"2014","unstructured":"Bricceno, K. V., Martinez, T., Leikina, E., Duguez, S., Partridge, T. A., Chernomordik, L. V., Fischbeck, K. H., Sumner, C. J., & Burnett, B. G. (2014). Survival motor neuron protein deficiency impairs myotube formation by altering myogenic gene expression and focal adhesion dynamics. Human Molecular Genetics, 23(18), 4745\u20134757. https:\/\/doi.org\/10.1093\/hmg\/ddu189","journal-title":"Human Molecular Genetics"},{"issue":"12","key":"162_CR32","doi-asserted-by":"publisher","first-page":"E2859","DOI":"10.1073\/pnas.1721670115","volume":"115","author":"M Briese","year":"2018","unstructured":"Briese, M., Saal-Bauernschubert, L., Ji, C., Moradi, M., Ghanawi, H., Uhl, M., Appenzeller, S., Backofen, R., & Sendtner, M. (2018). hnRNP R and its main interactor, the noncoding RNA 7SK, coregulate the axonal transcriptome of motoneurons [Research Support, Non-U.S. Gov\u2019t]. Proceedings of the National Academy of Sciences USA, 115(12), E2859\u2013E2868. https:\/\/doi.org\/10.1073\/pnas.1721670115","journal-title":"Proceedings of the National Academy of Sciences USA"},{"issue":"1","key":"162_CR33","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s40478-020-00987-6","volume":"8","author":"M Briese","year":"2020","unstructured":"Briese, M., Saal-Bauernschubert, L., Luningschror, P., Moradi, M., Dombert, B., Surrey, V., Appenzeller, S., Deng, C., Jablonka, S., & Sendtner, M. (2020). Loss of Tdp-43 disrupts the axonal transcriptome of motoneurons accompanied by impaired axonal translation and mitochondria function. Acta Neuropathologica Communications, 8(1), 116. https:\/\/doi.org\/10.1186\/s40478-020-00987-6","journal-title":"Acta Neuropathologica Communications"},{"issue":"4","key":"162_CR34","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1093\/nar\/gkv1027","volume":"44","author":"M Briese","year":"2016","unstructured":"Briese, M., Saal, L., Appenzeller, S., Moradi, M., Baluapuri, A., & Sendtner, M. (2016). Whole transcriptome profiling reveals the RNA content of motor axons. Nucleic Acids Research., 44(4), e33.","journal-title":"Nucleic Acids Research."},{"issue":"3","key":"162_CR35","first-page":"765","volume":"22","author":"O Broustal","year":"2010","unstructured":"Broustal, O., Camuzat, A., Guillot-Noel, L., Guy, N., Millecamps, S., Deffond, D., Lacomblez, L., Golfier, V., Hannequin, D., Salachas, F., Camu, W., Didic, M., Dubois, B., Meininger, V., Le Ber, I., Brice, A., French, C., & genetic research network on, F. F.-M. (2010). FUS mutations in frontotemporal lobar degeneration with amyotrophic lateral sclerosis. Journal of Alzheimer\u2019s Disease, 22(3), 765\u2013769.","journal-title":"Journal of Alzheimer's Disease"},{"issue":"5384","key":"162_CR36","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1126\/science.281.5384.1851","volume":"281","author":"LI Bruijn","year":"1998","unstructured":"Bruijn, L. I., Houseweart, M. K., Kato, S., Anderson, K. L., Anderson, S. D., Ohama, E., Reaume, A. G., Scott, R. W., & Cleveland, D. W. (1998). Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1 [Research Support, Non-U.S. Gov\u2019t Research Support, U.S. Gov\u2019t, P.H.S.]. Science, 281(5384), 1851\u20131854. https:\/\/doi.org\/10.1126\/science.281.5384.1851","journal-title":"Science"},{"issue":"1","key":"162_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1086\/513913","volume":"61","author":"AH Burghes","year":"1997","unstructured":"Burghes, A. H. (1997). When is a deletion not a deletion? When it is converted. American Journal of Human Genetics, 61(1), 9\u201315.","journal-title":"American Journal of Human Genetics"},{"issue":"12","key":"162_CR38","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1093\/hmg\/7.12.1927","volume":"7","author":"P Burlet","year":"1998","unstructured":"Burlet, P., Huber, C., Bertrandy, S., Ludosky, M. A., Zwaenepoel, I., Clermont, O., Roume, J., Delezoide, A. L., Cartaud, J., Munnich, A., & Lefebvre, S. (1998). The distribution of SMN protein complex in human fetal tissues and its alteration in spinal muscular atrophy. Human Molecular Genetics, 7(12), 1927\u20131933.","journal-title":"Human Molecular Genetics"},{"issue":"12","key":"162_CR39","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/s41589-019-0384-5","volume":"15","author":"S Campagne","year":"2019","unstructured":"Campagne, S., Boigner, S., Rudisser, S., Moursy, A., Gillioz, L., Knorlein, A., Hall, J., Ratni, H., Clery, A., & Allain, F. H. (2019). Structural basis of a small molecule targeting RNA for a specific splicing correction [Research Support, Non-U.S. Gov\u2019t]. Nature Chemical Biology, 15(12), 1191\u20131198. https:\/\/doi.org\/10.1038\/s41589-019-0384-5","journal-title":"Nature Chemical Biology"},{"issue":"1","key":"162_CR40","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1086\/513886","volume":"61","author":"L Campbell","year":"1997","unstructured":"Campbell, L., Potter, A., Ignatius, J., Dubowitz, V., & Davies, K. (1997). Genomic variation and gene conversion in spinal muscular atrophy: Implications for disease process and clinical phenotype. American Journal of Human Genetics, 61(1), 40\u201350.","journal-title":"American Journal of Human Genetics"},{"issue":"2","key":"162_CR41","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.ccm.2018.01.004","volume":"39","author":"JC Carter","year":"2018","unstructured":"Carter, J. C., Sheehan, D. W., Prochoroff, A., & Birnkrant, D. J. (2018). Muscular dystrophies [review]. Clinics in Chest Medicine, 39(2), 377\u2013389. https:\/\/doi.org\/10.1016\/j.ccm.2018.01.004","journal-title":"Clinics in Chest Medicine"},{"issue":"1","key":"162_CR42","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S1474-4422(17)30401-5","volume":"17","author":"R Chia","year":"2018","unstructured":"Chia, R., Chio, A., & Traynor, B. J. (2018). Novel genes associated with amyotrophic lateral sclerosis: Diagnostic and clinical implications [Review]. Lancet Neurology, 17(1), 94\u2013102. https:\/\/doi.org\/10.1016\/S1474-4422(17)30401-5","journal-title":"Lancet Neurology"},{"issue":"4","key":"162_CR43","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/mt.2013.246","volume":"22","author":"LG Chicoine","year":"2014","unstructured":"Chicoine, L. G., Rodino-Klapac, L. R., Shao, G., Xu, R., Bremer, W. G., Camboni, M., Golden, B., Montgomery, C. L., Shontz, K., Heller, K. N., Griffin, D. A., Lewis, S., Coley, B. D., Walker, C. M., Clark, K. R., Sahenk, Z., Mendell, J. R., & Martin, P. T. (2014). Vascular delivery of rAAVrh74.MCK.GALGT2 to the gastrocnemius muscle of the rhesus macaque stimulates the expression of dystrophin and laminin alpha2 surrogates [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov\u2019t]. Molecular Therapy, 22(4), 713\u2013724. https:\/\/doi.org\/10.1038\/mt.2013.246","journal-title":"Molecular Therapy"},{"issue":"10","key":"162_CR44","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1212\/WNL.0000000000002445","volume":"86","author":"CA Chiriboga","year":"2016","unstructured":"Chiriboga, C. A., Swoboda, K. J., Darras, B. T., Iannaccone, S. T., Montes, J., De Vivo, D. C., Norris, D. A., Bennett, C. F., & Bishop, K. M. (2016). Results from a phase 1 study of nusinersen (ISIS-SMN(Rx)) in children with spinal muscular atrophy [Clinical Trial, Phase I Multicenter Study Research Support, Non-U.S. Gov\u2019t]. Neurology, 86(10), 890\u2013897. https:\/\/doi.org\/10.1212\/WNL.0000000000002445","journal-title":"Neurology"},{"issue":"5","key":"162_CR45","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1101\/gad.1884910","volume":"24","author":"S Cho","year":"2010","unstructured":"Cho, S., & Dreyfuss, G. (2010). A degron created by SMN2 exon 7 skipping is a principal contributor to spinal muscular atrophy severity [Research Support, Non-U.S. Gov\u2019t]. Genes & Development, 24(5), 438\u2013442. https:\/\/doi.org\/10.1101\/gad.1884910","journal-title":"Genes & Development"},{"issue":"20","key":"162_CR46","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1212\/WNL.0b013e3181c29356","volume":"73","author":"CW Christine","year":"2009","unstructured":"Christine, C. W., Starr, P. A., Larson, P. S., Eberling, J. L., Jagust, W. J., Hawkins, R. A., VanBrocklin, H. F., Wright, J. F., Bankiewicz, K. S., & Aminoff, M. J. (2009). Safety and tolerability of putaminal AADC gene therapy for Parkinson disease. Neurology, 73(20), 1662\u20131669. https:\/\/doi.org\/10.1212\/WNL.0b013e3181c29356","journal-title":"Neurology"},{"issue":"5","key":"162_CR47","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1083\/jcb.152.5.1107","volume":"152","author":"C Cifuentes-Diaz","year":"2001","unstructured":"Cifuentes-Diaz, C., Frugier, T., Tiziano, F. D., Lacene, E., Roblot, N., Joshi, V., Moreau, M. H., & Melki, J. (2001). Deletion of murine SMN exon 7 directed to skeletal muscle leads to severe muscular dystrophy. Journal of Cell Biology, 152(5), 1107\u20131114. https:\/\/doi.org\/10.1083\/jcb.152.5.1107","journal-title":"Journal of Cell Biology"},{"issue":"6555","key":"162_CR48","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/378342a0","volume":"378","author":"DW Cleveland","year":"1995","unstructured":"Cleveland, D. W., Laing, N., Hurse, P. V., & Brown, R. H., Jr. (1995). Toxic mutants in Charcot\u2019s sclerosis [Comment Letter]. Nature, 378(6555), 342\u2013343. https:\/\/doi.org\/10.1038\/378342a0","journal-title":"Nature"},{"issue":"7","key":"162_CR49","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","volume":"14","author":"EE Congdon","year":"2018","unstructured":"Congdon, E. E., & Sigurdsson, E. M. (2018). Tau-targeting therapies for Alzheimer disease [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov\u2019t Review]. Nature Reviews Neurology, 14(7), 399\u2013415. https:\/\/doi.org\/10.1038\/s41582-018-0013-z","journal-title":"Nature Reviews Neurology"},{"issue":"8","key":"162_CR50","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1093\/hmg\/6.8.1205","volume":"6","author":"DD Coovert","year":"1997","unstructured":"Coovert, D. D., Le, T. T., McAndrew, P. E., Strasswimmer, J., Crawford, T. O., Mendell, J. R., Coulson, S. E., Androphy, E. J., Prior, T. W., & Burghes, A. H. (1997). The survival motor neuron protein in spinal muscular atrophy. Human Molecular Genetics, 6(8), 1205\u20131214.","journal-title":"Human Molecular Genetics"},{"issue":"6","key":"162_CR51","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/S0896-6273(00)80652-2","volume":"21","author":"GA Cox","year":"1998","unstructured":"Cox, G. A., Mahaffey, C. L., & Frankel, W. N. (1998). Identification of the mouse neuromuscular degeneration gene and mapping of a second site suppressor allele. Neuron, 21(6), 1327\u20131337.","journal-title":"Neuron"},{"issue":"R1","key":"162_CR52","doi-asserted-by":"publisher","first-page":"R102","DOI":"10.1093\/hmg\/ddz128","volume":"28","author":"JM Crudele","year":"2019","unstructured":"Crudele, J. M., & Chamberlain, J. S. (2019). AAV-based gene therapies for the muscular dystrophies. Human Molecular Genetics, 28(R1), R102\u2013R107. https:\/\/doi.org\/10.1093\/hmg\/ddz128","journal-title":"Human Molecular Genetics"},{"issue":"1","key":"162_CR53","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neuron.2016.11.033","volume":"93","author":"C d'Ydewalle","year":"2017","unstructured":"d\u2019Ydewalle, C., Ramos, D. M., Pyles, N. J., Ng, S. Y., Gorz, M., Pilato, C. M., Ling, K., Kong, L., Ward, A. J., Rubin, L. L., Rigo, F., Bennett, C. F., & Sumner, C. J. (2017). The antisense transcript SMN-AS1 regulates SMN expression and is a novel therapeutic target for spinal muscular atrophy. Neuron, 93(1), 66\u201379.","journal-title":"Neuron"},{"issue":"21","key":"162_CR54","doi-asserted-by":"publisher","first-page":"e2492","DOI":"10.1212\/WNL.0000000000007527","volume":"92","author":"BT Darras","year":"2019","unstructured":"Darras, B. T., Chiriboga, C. A., Iannaccone, S. T., Swoboda, K. J., Montes, J., Mignon, L., Xia, S., Bennett, C. F., Bishop, K. M., Shefner, J. M., Green, A. M., Sun, P., Bhan, I., Gheuens, S., Schneider, E., Farwell, W., De Vivo, D. C., & Groups, I.-C. I.-C. S. (2019). Nusinersen in later-onset spinal muscular atrophy: Long-term results from the phase 1\/2 studies [Clinical Trial, Phase I Clinical Trial, Phase II Multicenter Study Research Support, Non-U.S. Gov\u2019t]. Neurology, 92(21), e2492\u2013e2506. https:\/\/doi.org\/10.1212\/WNL.0000000000007527","journal-title":"Neurology"},{"issue":"5","key":"162_CR55","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1056\/NEJMoa2102047","volume":"385","author":"BT Darras","year":"2021","unstructured":"Darras, B. T., Masson, R., Mazurkiewicz-Beldzinska, M., Rose, K., Xiong, H., Zanoteli, E., Baranello, G., Bruno, C., Vlodavets, D., Wang, Y., El-Khairi, M., Gerber, M., Gorni, K., Khwaja, O., Kletzl, H., Scalco, R. S., Fontoura, P., Servais, L., & Group, F. W. (2021). Risdiplam-treated infants with Type 1 spinal muscular atrophy versus historical controls. New England Journal of Medicine, 385(5), 427\u2013435. https:\/\/doi.org\/10.1056\/NEJMoa2102047","journal-title":"New England Journal of Medicine"},{"issue":"10","key":"162_CR56","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1038\/s41591-019-0604-2","volume":"25","author":"KE Davies","year":"2019","unstructured":"Davies, K. E., & Chamberlain, J. S. (2019). Surrogate gene therapy for muscular dystrophy. Nature Medicine, 25(10), 1473\u20131474. https:\/\/doi.org\/10.1038\/s41591-019-0604-2","journal-title":"Nature Medicine"},{"issue":"4","key":"162_CR57","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S1474-4422(21)00001-6","volume":"20","author":"JW Day","year":"2021","unstructured":"Day, J. W., Finkel, R. S., Chiriboga, C. A., Connolly, A. M., Crawford, T. O., Darras, B. T., Iannaccone, S. T., Kuntz, N. L., Pena, L. D. M., Shieh, P. B., Smith, E. C., Kwon, J. M., Zaidman, C. M., Schultz, M., Feltner, D. E., Tauscher-Wisniewski, S., Ouyang, H., Chand, D. H., Sproule, D. M., \u2026 Mendell, J. R. (2021). Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): An open-label, single-arm, multicentre, phase 3 trial. Lancet Neurology, 20(4), 284\u2013293. https:\/\/doi.org\/10.1016\/S1474-4422(21)00001-6","journal-title":"Lancet Neurology"},{"key":"162_CR58","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.omtm.2021.02.014","volume":"21","author":"JW Day","year":"2021","unstructured":"Day, J. W., Finkel, R. S., Mercuri, E., Swoboda, K. J., Menier, M., van Olden, R., Tauscher-Wisniewski, S., & Mendell, J. R. (2021). Adeno-associated virus serotype 9 antibodies in patients screened for treatment with onasemnogene abeparvovec. Molecular Therapy - Methods & Clinical Development, 21, 76\u201382. https:\/\/doi.org\/10.1016\/j.omtm.2021.02.014","journal-title":"Molecular Therapy - Methods & Clinical Development"},{"issue":"11","key":"162_CR59","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.nmd.2019.09.007","volume":"29","author":"DC De Vivo","year":"2019","unstructured":"De Vivo, D. C., Bertini, E., Swoboda, K. J., Hwu, W. L., Crawford, T. O., Finkel, R. S., Kirschner, J., Kuntz, N. L., Parsons, J. A., Ryan, M. M., Butterfield, R. J., Topaloglu, H., Ben-Omran, T., Sansone, V. A., Jong, Y. J., Shu, F., Staropoli, J. F., Kerr, D., Sandrock, A. W., \u2026 Group, N. S. (2019). Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study. Neuromuscular Disorders, 29(11), 842\u2013856. https:\/\/doi.org\/10.1016\/j.nmd.2019.09.007","journal-title":"Neuromuscular Disorders"},{"issue":"2","key":"162_CR60","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","volume":"72","author":"M DeJesus-Hernandez","year":"2011","unstructured":"DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., Kouri, N., Wojtas, A., Sengdy, P., Hsiung, G. Y., Karydas, A., Seeley, W. W., Josephs, K. A., Coppola, G., Geschwind, D. H., \u2026 Rademakers, R. (2011). Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov\u2019t]. Neuron, 72(2), 245\u2013256. https:\/\/doi.org\/10.1016\/j.neuron.2011.09.011","journal-title":"Neuron"},{"issue":"6","key":"162_CR61","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nrneurol.2014.78","volume":"10","author":"H Deng","year":"2014","unstructured":"Deng, H., Gao, K., & Jankovic, J. (2014). The role of FUS gene variants in neurodegenerative diseases [Research Support, Non-U.S. Gov\u2019t Review]. Nature Reviews Neurology, 10(6), 337\u2013348. https:\/\/doi.org\/10.1038\/nrneurol.2014.78","journal-title":"Nature Reviews Neurology"},{"issue":"5124","key":"162_CR62","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1126\/science.8351519","volume":"261","author":"HX Deng","year":"1993","unstructured":"Deng, H. X., Hentati, A., Tainer, J. A., Iqbal, Z., Cayabyab, A., Hung, W. Y., Getzoff, E. D., Hu, P., Herzfeldt, B., & Roos, R. P. (1993). Amyotrophic lateral sclerosis and structural defects in Cu, Zn superoxide dismutase. Science, 261(5124), 1047\u20131051.","journal-title":"Science"},{"key":"162_CR63","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3389\/fimmu.2020.00168","volume":"11","author":"Q Deveuve","year":"2020","unstructured":"Deveuve, Q., Lajoie, L., Barrault, B., & Thibault, G. (2020). The proteolytic cleavage of therapeutic monoclonal antibody hinge region: More than a matter of subclass. Frontiers in Immunology, 11, 168. https:\/\/doi.org\/10.3389\/fimmu.2020.00168","journal-title":"Frontiers in Immunology"},{"issue":"30","key":"162_CR64","doi-asserted-by":"publisher","first-page":"E4377","DOI":"10.1073\/pnas.1600015113","volume":"113","author":"M Dimitriadi","year":"2016","unstructured":"Dimitriadi, M., Derdowski, A., Kalloo, G., Maginnis, M. S., O\u2019Hern, P., Bliska, B., Sorkac, A., Nguyen, K. C., Cook, S. J., Poulogiannis, G., Atwood, W. J., Hall, D. H., & Hart, A. C. (2016). Decreased function of survival motor neuron protein impairs endocytic pathways [Research Support, N.I.H., Extramural]. Proceedings of the National Academy of Sciences USA, 113(30), E4377-4386. https:\/\/doi.org\/10.1073\/pnas.1600015113","journal-title":"Proceedings of the National Academy of Sciences USA"},{"issue":"10","key":"162_CR65","doi-asserted-by":"publisher","first-page":"e1001172","DOI":"10.1371\/journal.pgen.1001172","volume":"6","author":"M Dimitriadi","year":"2010","unstructured":"Dimitriadi, M., Sleigh, J. N., Walker, A., Chang, H. C., Sen, A., Kalloo, G., Harris, J., Barsby, T., Walsh, M. B., Satterlee, J. S., Li, C., Van Vactor, D., Artavanis-Tsakonas, S., & Hart, A. C. (2010). Conserved genes act as modifiers of invertebrate SMN loss of function defects [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov\u2019t]. PLoS Genetics, 6(10), e1001172. https:\/\/doi.org\/10.1371\/journal.pgen.1001172","journal-title":"PLoS Genetics"},{"issue":"1","key":"162_CR66","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1093\/nar\/gkw731","volume":"45","author":"TK Doktor","year":"2017","unstructured":"Doktor, T. K., Hua, Y., Andersen, H. S., Broner, S., Liu, Y. H., Wieckowska, A., Dembic, M., Bruun, G. H., Krainer, A. R., & Andresen, B. S. (2017). RNA-sequencing of a mouse-model of spinal muscular atrophy reveals tissue-wide changes in splicing of U12-dependent introns. Nucleic Acids Research, 45(1), 395\u2013416. https:\/\/doi.org\/10.1093\/nar\/gkw731","journal-title":"Nucleic Acids Research"},{"key":"162_CR67","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3389\/fnmol.2017.00346","volume":"10","author":"B Dombert","year":"2017","unstructured":"Dombert, B., Balk, S., Luningschror, P., Moradi, M., Sivadasan, R., Saal-Bauernschubert, L., & Jablonka, S. (2017). BDNF\/trkB induction of calcium transients through Cav2.2 calcium channels in motoneurons corresponds to F-actin assembly and growth cone formation on beta2-Chain Laminin (221). Frontiers in Molecular Neuroscience, 10, 346. https:\/\/doi.org\/10.3389\/fnmol.2017.00346","journal-title":"Frontiers in Molecular Neuroscience"},{"issue":"10","key":"162_CR68","doi-asserted-by":"publisher","first-page":"e11046","DOI":"10.1371\/journal.pone.0110846","volume":"9","author":"B Dombert","year":"2014","unstructured":"Dombert, B., Sivadasan, R., Simon, C. M., Jablonka, S., & Sendtner, M. (2014). Presynaptic localization of Smn and hnRNP R in axon terminals of embryonic and postnatal mouse motoneurons. PLoS ONE, 9(10), e11046.","journal-title":"PLoS ONE"},{"key":"162_CR69","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1093\/brain\/87.4.707","volume":"87","author":"V Dubowitz","year":"1964","unstructured":"Dubowitz, V. (1964). Infantile muscular atrophy. A prospective study with particular reference to a slowly progressive variety. Brain, 87, 707\u2013718. https:\/\/doi.org\/10.1093\/brain\/87.4.707","journal-title":"Brain"},{"issue":"1","key":"162_CR70","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0960-8966(94)00075-K","volume":"5","author":"V Dubowitz","year":"1995","unstructured":"Dubowitz, V. (1995). Chaos in the classification of SMA: A possible resolution. Neuromuscular Disorders, 5(1), 3\u20135.","journal-title":"Neuromuscular Disorders"},{"issue":"5","key":"162_CR71","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1086\/302372","volume":"64","author":"A Echaniz-Laguna","year":"1999","unstructured":"Echaniz-Laguna, A., Miniou, P., Bartholdi, D., & Melki, J. (1999). The promoters of the survival motor neuron gene (SMN) and its copy (SMNc) share common regulatory elements. American Journal of Human Genetics, 64(5), 1365\u20131370.","journal-title":"American Journal of Human Genetics"},{"issue":"R2","key":"162_CR72","doi-asserted-by":"publisher","first-page":"R163","DOI":"10.1093\/hmg\/ddy171","volume":"27","author":"L Echevarria","year":"2018","unstructured":"Echevarria, L., Aupy, P., & Goyenvalle, A. (2018). Exon-skipping advances for Duchenne muscular dystrophy [Research Support, Non-U.S. Gov\u2019t Review]. Human Molecular Genetics, 27(R2), R163\u2013R172. https:\/\/doi.org\/10.1093\/hmg\/ddy171","journal-title":"Human Molecular Genetics"},{"issue":"11","key":"162_CR73","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1016\/j.ymthe.2019.07.012","volume":"27","author":"Y Echigoya","year":"2019","unstructured":"Echigoya, Y., Lim, K. R. Q., Melo, D., Bao, B., Trieu, N., Mizobe, Y., Maruyama, R., Mamchaoui, K., Tanihata, J., Aoki, Y., Takeda, S., Mouly, V., Duddy, W., & Yokota, T. (2019). Exons 45-55 Skipping Using Mutation-Tailored Cocktails of Antisense Morpholinos in the DMD Gene [Research Support, Non-U.S. Gov\u2019t]. Molecular Therapy, 27(11), 2005\u20132017. https:\/\/doi.org\/10.1016\/j.ymthe.2019.07.012","journal-title":"Molecular Therapy"},{"issue":"4","key":"162_CR74","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3390\/jpm8040041","volume":"8","author":"Y Echigoya","year":"2018","unstructured":"Echigoya, Y., Lim, K. R. Q., Nakamura, A., & Yokota, T. (2018). Multiple exon skipping in the Duchenne muscular dystrophy hot spots: Prospects and challenges [review]. Journal of Personalized Medicine, 8(4), 41. https:\/\/doi.org\/10.3390\/jpm8040041","journal-title":"Journal of Personalized Medicine"},{"key":"162_CR75","doi-asserted-by":"publisher","DOI":"10.3233\/JND-210678","author":"N Elangkovan","year":"2021","unstructured":"Elangkovan, N., & Dickson, G. (2021). Gene therapy for Duchenne muscular dystrophy. Journal of Neuromuscular Diseases. https:\/\/doi.org\/10.3233\/JND-210678","journal-title":"Journal of Neuromuscular Diseases"},{"issue":"7310","key":"162_CR76","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nature09320","volume":"466","author":"AC Elden","year":"2010","unstructured":"Elden, A. C., Kim, H. J., Hart, M. P., Chen-Plotkin, A. S., Johnson, B. S., Fang, X., Armakola, M., Geser, F., Greene, R., Lu, M. M., Padmanabhan, A., Clay-Falcone, D., McCluskey, L., Elman, L., Juhr, D., Gruber, P. J., Rub, U., Auburger, G., Trojanowski, J. Q., \u2026 Gitler, A. D. (2010). Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature, 466(7310), 1069\u20131075. https:\/\/doi.org\/10.1038\/nature09320","journal-title":"Nature"},{"issue":"1","key":"162_CR77","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0960-8966(91)90039-U","volume":"1","author":"AE Emery","year":"1991","unstructured":"Emery, A. E. (1991). Population frequencies of inherited neuromuscular diseases\u2013a world survey. Neuromuscular Disorders, 1(1), 19\u201329.","journal-title":"Neuromuscular Disorders"},{"issue":"1","key":"162_CR78","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0022-510x(76)90082-4","volume":"29","author":"AE Emery","year":"1976","unstructured":"Emery, A. E., Hausmanowa-Petrusewicz, I., Davie, A. M., Holloway, S., Skinner, R., & Borkowska, J. (1976). International collaborative study of the spinal muscular atrophies. Part 1. Analysis of clinical and laboratory data. Journal of the Neurological Sciences, 29(1), 83\u201394. https:\/\/doi.org\/10.1016\/0022-510x(76)90082-4","journal-title":"Journal of the Neurological Sciences"},{"issue":"6254","key":"162_CR79","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/343180a0","volume":"343","author":"SB England","year":"1990","unstructured":"England, S. B., Nicholson, L. V., Johnson, M. A., Forrest, S. M., Love, D. R., Zubrzycka-Gaarn, E. E., Bulman, D. E., Harris, J. B., & Davies, K. E. (1990). Very mild muscular dystrophy associated with the deletion of 46% of dystrophin. Nature, 343(6254), 180\u2013182. https:\/\/doi.org\/10.1038\/343180a0","journal-title":"Nature"},{"issue":"24","key":"162_CR80","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1056\/NEJMoa033447","volume":"351","author":"S Fahn","year":"2004","unstructured":"Fahn, S., Oakes, D., Shoulson, I., Kieburtz, K., Rudolph, A., Lang, A., Olanow, C. W., Tanner, C., & Marek, K. (2004). Levodopa and the progression of Parkinson\u2019s disease [Clinical Trial Multicenter Study Randomized Controlled Trial Research Support, U.S. Gov\u2019t, Non-P.H.S. Research Support, U.S. Gov\u2019t, P.H.S.]. New England Journal of Medicine, 351(24), 2498\u20132508. https:\/\/doi.org\/10.1056\/NEJMoa033447","journal-title":"New England Journal of Medicine"},{"key":"162_CR81","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.brainres.2012.01.044","volume":"1462","author":"C Fallini","year":"2012","unstructured":"Fallini, C., Bassell, G. J., & Rossoll, W. (2012). Spinal muscular atrophy: The role of SMN in axonal mRNA regulation. Brain Research, 1462, 81\u201392.","journal-title":"Brain Research"},{"issue":"10","key":"162_CR82","doi-asserted-by":"publisher","first-page":"3914","DOI":"10.1523\/JNEUROSCI.3631-10.2011","volume":"31","author":"C Fallini","year":"2011","unstructured":"Fallini, C., Zhang, H., Su, Y., Silani, V., Singer, R. H., Rossoll, W., & Bassell, G. J. (2011). The survival of motor neuron (SMN) protein interacts with the mRNA-binding protein HuD and regulates localization of poly(A) mRNA in primary motor neuron axons. Journal of Neuroscience, 31(10), 3914\u20133925.","journal-title":"Journal of Neuroscience"},{"issue":"9","key":"162_CR83","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1136\/jnnp-2017-317412","volume":"89","author":"MA Farrar","year":"2018","unstructured":"Farrar, M. A., Teoh, H. L., Carey, K. A., Cairns, A., Forbes, R., Herbert, K., Holland, S., Jones, K. J., Menezes, M. P., Morrison, M., Munro, K., Villano, D., Webster, R., Woodcock, I. R., Yiu, E. M., Sampaio, H., & Ryan, M. M. (2018). Nusinersen for SMA: expanded access programme [Multicenter Study Research Support, Non-U.S. Gov\u2019t]. Journal of Neurology, Neurosurgery & Psychiatry, 89(9), 937\u2013942. https:\/\/doi.org\/10.1136\/jnnp-2017-317412","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"2","key":"162_CR84","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1159\/000140989","volume":"23","author":"B Feinstein","year":"1955","unstructured":"Feinstein, B., Lindegard, B., Nyman, E., & Wohlfart, G. (1955). Morphologic studies of motor units in normal human muscles. Acta Anatomica (Basel), 23(2), 127\u2013142. https:\/\/doi.org\/10.1159\/000140989","journal-title":"Acta Anatomica (Basel)"},{"issue":"2","key":"162_CR85","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1086\/338627","volume":"70","author":"M Feldkotter","year":"2002","unstructured":"Feldkotter, M., Schwarzer, V., Wirth, R., Wienker, T. F., & Wirth, B. (2002). Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy [Research Support, Non-U.S. Gov\u2019t]. The American Journal of Human Genetics, 70(2), 358\u2013368. https:\/\/doi.org\/10.1086\/338627","journal-title":"The American Journal of Human Genetics"},{"issue":"5","key":"162_CR86","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1093\/hmg\/ddv629","volume":"25","author":"Z Feng","year":"2016","unstructured":"Feng, Z., Ling, K. K., Zhao, X., Zhou, C., Karp, G., Welch, E. M., Naryshkin, N., Ratni, H., Chen, K. S., Metzger, F., Paushkin, S., Weetall, M., & Ko, C. P. (2016). Pharmacologically induced mouse model of adult spinal muscular atrophy to evaluate effectiveness of therapeutics after disease onset. Human Molecular Genetics, 25(5), 964\u2013975. https:\/\/doi.org\/10.1093\/hmg\/ddv629","journal-title":"Human Molecular Genetics"},{"issue":"Pt 2","key":"162_CR87","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/brain\/113.2.433","volume":"113","author":"A Fidzianska","year":"1990","unstructured":"Fidzianska, A., Goebel, H. H., & Warlo, I. (1990). Acute infantile spinal muscular atrophy. Muscle apoptosis as a proposed pathogenetic mechanism. Brain, 113(Pt 2), 433\u2013445. https:\/\/doi.org\/10.1093\/brain\/113.2.433","journal-title":"Brain"},{"issue":"10063","key":"162_CR88","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1016\/S0140-6736(16)31408-8","volume":"388","author":"RS Finkel","year":"2016","unstructured":"Finkel, R. S., Chiriboga, C. A., Vajsar, J., Day, J. W., Montes, J., De Vivo, D. C., Yamashita, M., Rigo, F., Hung, G., Schneider, E., Norris, D. A., Xia, S., Bennett, C. F., & Bishop, K. M. (2016). Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study [Clinical Trial, Phase II Research Support, Non-U.S. Gov\u2019t]. Lancet, 388(10063), 3017\u20133026. https:\/\/doi.org\/10.1016\/S0140-6736(16)31408-8","journal-title":"Lancet"},{"issue":"18","key":"162_CR89","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","volume":"377","author":"RS Finkel","year":"2017","unstructured":"Finkel, R. S., Mercuri, E., Darras, B. T., Connolly, A. M., Kuntz, N. L., Kirschner, J., Chiriboga, C. A., Saito, K., Servais, L., Tizzano, E., Topaloglu, H., Tulinius, M., Montes, J., Glanzman, A. M., Bishop, K., Zhong, Z. J., Gheuens, S., Bennett, C. F., Schneider, E., \u2026 Group, E. S. (2017). Nusinersen versus Sham control in infantile-onset spinal muscular atrophy [Clinical Trial, Phase III Multicenter Study Randomized Controlled Trial]. New England Journal of Medicine, 377(18), 1723\u20131732. https:\/\/doi.org\/10.1056\/NEJMoa1702752","journal-title":"New England Journal of Medicine"},{"key":"162_CR90","doi-asserted-by":"crossref","first-page":"P1.6-059","DOI":"10.1212\/WNL.92.15_supplement.P1.6-059","volume":"92","author":"RS Finkel","year":"2019","unstructured":"Finkel, R. S., Day, J. W., Darras, B. T., Kuntz, N. L., Connolly, A. M., et al. (2019). Phase 1 study of intrathecal administration of AVXS-101 gene-replacement therapy (GRT) for spinal muscular atrophy type 2 (SMA2) (STRONG) (P1.6-059). Neurology, 92, P1.6-059.","journal-title":"Neurology"},{"key":"162_CR91","doi-asserted-by":"crossref","unstructured":"Fischer, U., Liu, Q., & Dreyfuss, G. (1997). The SMN-SIP1 complex has an essential role in spliceosomal snRNP biogenesis. Cell 77(5), 727\u2013736, 90(6), 1023\u20131029.","DOI":"10.1016\/S0092-8674(00)80368-2"},{"issue":"1","key":"162_CR92","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nbt.1515","volume":"27","author":"KD Foust","year":"2009","unstructured":"Foust, K. D., Nurre, E., Montgomery, C. L., Hernandez, A., Chan, C. M., & Kaspar, B. K. (2009). Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov\u2019t]. Nature Biotechnology, 27(1), 59\u201365. https:\/\/doi.org\/10.1038\/nbt.1515","journal-title":"Nature Biotechnology"},{"issue":"3","key":"162_CR93","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nbt.1610","volume":"28","author":"KD Foust","year":"2010","unstructured":"Foust, K. D., Wang, X., McGovern, V. L., Braun, L., Bevan, A. K., Haidet, A. M., Le, T. T., Morales, P. R., Rich, M. M., Burghes, A. H., & Kaspar, B. K. (2010). Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN. Nature Biotechnology, 28(3), 271\u2013274.","journal-title":"Nature Biotechnology"},{"key":"162_CR94","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3389\/fnmol.2017.00035","volume":"10","author":"BD Freibaum","year":"2017","unstructured":"Freibaum, B. D., & Taylor, J. P. (2017). The role of dipeptide repeats in C9ORF72-related ALS-FTD [review]. Frontiers in Molecular Neuroscience, 10, 35. https:\/\/doi.org\/10.3389\/fnmol.2017.00035","journal-title":"Frontiers in Molecular Neuroscience"},{"issue":"6","key":"162_CR95","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.cub.2005.01.058","volume":"15","author":"R Fujii","year":"2005","unstructured":"Fujii, R., Okabe, S., Urushido, T., Inoue, K., Yoshimura, A., Tachibana, T., Nishikawa, T., Hicks, G. G., & Takumi, T. (2005). The RNA binding protein TLS is translocated to dendritic spines by mGluR5 activation and regulates spine morphology. Current Biology, 15(6), 587\u2013593. https:\/\/doi.org\/10.1016\/j.cub.2005.01.058","journal-title":"Current Biology"},{"issue":"Pt 24","key":"162_CR96","doi-asserted-by":"publisher","first-page":"5755","DOI":"10.1242\/jcs.02692","volume":"118","author":"R Fujii","year":"2005","unstructured":"Fujii, R., & Takumi, T. (2005). TLS facilitates transport of mRNA encoding an actin-stabilizing protein to dendritic spines [Research Support, Non-U.S. Gov\u2019t]. Journal of Cell Science, 118(Pt 24), 5755\u20135765. https:\/\/doi.org\/10.1242\/jcs.02692","journal-title":"Journal of Cell Science"},{"issue":"23","key":"162_CR97","doi-asserted-by":"publisher","first-page":"3629","DOI":"10.1093\/hmg\/ddi390","volume":"14","author":"F Gabanella","year":"2005","unstructured":"Gabanella, F., Carissimi, C., Usiello, A., & Pellizzoni, L. (2005). The activity of the spinal muscular atrophy protein is regulated during development and cellular differentiation [Research Support, Non-U.S. Gov\u2019t]. Human Molecular Genetics, 14(23), 3629\u20133642. https:\/\/doi.org\/10.1093\/hmg\/ddi390","journal-title":"Human Molecular Genetics"},{"issue":"11","key":"162_CR98","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1261\/rna.038919.113","volume":"19","author":"EL Garcia","year":"2013","unstructured":"Garcia, E. L., Lu, Z., Meers, M. P., Praveen, K., & Matera, A. G. (2013). Developmental arrest of Drosophila survival motor neuron (Smn) mutants accounts for differences in expression of minor intron-containing genes. RNA, 19(11), 1510\u20131516.","journal-title":"RNA"},{"issue":"8","key":"162_CR99","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1093\/hmg\/ddm379","volume":"17","author":"TO Gavrilina","year":"2008","unstructured":"Gavrilina, T. O., McGovern, V. L., Workman, E., Crawford, T. O., Gogliotti, R. G., DiDonato, C. J., Monani, U. R., Morris, G. E., & Burghes, A. H. (2008). Neuronal SMN expression corrects spinal muscular atrophy in severe SMA mice while muscle-specific SMN expression has no phenotypic effect [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov\u2019t]. Human Molecular Genetics, 17(8), 1063\u20131075. https:\/\/doi.org\/10.1093\/hmg\/ddm379","journal-title":"Human Molecular Genetics"},{"issue":"1","key":"162_CR100","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/dmcn.14027","volume":"61","author":"T Gidaro","year":"2019","unstructured":"Gidaro, T., & Servais, L. (2019). Nusinersen treatment of spinal muscular atrophy: Current knowledge and existing gaps [Review]. Developmental Medicine and Child Neurology, 61(1), 19\u201324. https:\/\/doi.org\/10.1111\/dmcn.14027","journal-title":"Developmental Medicine and Child Neurology"},{"issue":"3","key":"162_CR101","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.cell.2014.09.029","volume":"159","author":"LA Gilbert","year":"2014","unstructured":"Gilbert, L. A., Horlbeck, M. A., Adamson, B., Villalta, J. E., Chen, Y., Whitehead, E. H., Guimaraes, C., Panning, B., Ploegh, H. L., Bassik, M. C., Qi, L. S., Kampmann, M., & Weissman, J. S. (2014). Genome-scale CRISPR-mediated control of gene repression and activation [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov\u2019t]. Cell, 159(3), 647\u2013661. https:\/\/doi.org\/10.1016\/j.cell.2014.09.029","journal-title":"Cell"},{"issue":"10","key":"162_CR102","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1093\/hmg\/ddq073","volume":"19","author":"M Glinka","year":"2010","unstructured":"Glinka, M., Herrmann, T., Funk, N., Havlicek, S., Rossoll, W., Winkler, C., & Sendtner, M. (2010). The heterogeneous nuclear ribonucleoprotein-R is necessary for axonal beta-actin mRNA translocation in spinal motor neurons. Human Molecular Genetics, 19(10), 1951\u20131966.","journal-title":"Human Molecular Genetics"},{"issue":"11","key":"162_CR103","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.1523\/JNEUROSCI.5775-11.2012","volume":"32","author":"RG Gogliotti","year":"2012","unstructured":"Gogliotti, R. G., Quinlan, K. A., Barlow, C. B., Heier, C. R., Heckman, C. J., & Didonato, C. J. (2012). Motor neuron rescue in spinal muscular atrophy mice demonstrates that sensory-motor defects are a consequence, not a cause, of motor neuron dysfunction. Journal of Neuroscience, 32(11), 3818\u20133829. https:\/\/doi.org\/10.1523\/JNEUROSCI.5775-11.2012","journal-title":"Journal of Neuroscience"},{"issue":"12","key":"162_CR104","doi-asserted-by":"publisher","first-page":"E2466","DOI":"10.1073\/pnas.1614462114","volume":"114","author":"PP Gopal","year":"2017","unstructured":"Gopal, P. P., Nirschl, J. J., Klinman, E., & Holzbaur, E. L. (2017). Amyotrophic lateral sclerosis-linked mutations increase the viscosity of liquid-like TDP-43 RNP granules in neurons. Proceedings of the National Academy of Sciences USA, 114(12), E2466\u2013E2475. https:\/\/doi.org\/10.1073\/pnas.1614462114","journal-title":"Proceedings of the National Academy of Sciences USA"},{"issue":"7014","key":"162_CR105","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature03120","volume":"432","author":"RI Gregory","year":"2004","unstructured":"Gregory, R. I., Yan, K. P., Amuthan, G., Chendrimada, T., Doratotaj, B., Cooch, N., & Shiekhattar, R. (2004). The Microprocessor complex mediates the genesis of microRNAs [Research Support, Non-U.S. Gov\u2019t Research Support, U.S. Gov\u2019t, Non-P.H.S. Research Support, U.S. Gov\u2019t, P.H.S.]. Nature, 432(7014), 235\u2013240. https:\/\/doi.org\/10.1038\/nature03120","journal-title":"Nature"},{"issue":"18","key":"162_CR106","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1093\/hmg\/ddh222","volume":"13","author":"K Grohmann","year":"2004","unstructured":"Grohmann, K., Rossoll, W., Kobsar, I., Holtmann, B., Jablonka, S., Wessig, C., Stoltenburg-Didinger, G., Fischer, U., Hubner, C., Martini, R., & Sendtner, M. (2004). Characterization of Ighmbp2 in motor neurons and implications for the pathomechanism in a mouse model of human spinal muscular atrophy with respiratory distress type 1 (SMARD1). Human Molecular Genetics, 13(18), 2031\u20132042.","journal-title":"Human Molecular Genetics"},{"issue":"1","key":"162_CR107","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/ng703","volume":"29","author":"K Grohmann","year":"2001","unstructured":"Grohmann, K., Schuelke, M., Diers, A., Hoffmann, K., Lucke, B., Adams, C., Bertini, E., Leonhardt-Horti, H., Muntoni, F., Ouvrier, R., Pfeufer, A., Rossi, R., Van Maldergem, L., Wilmshurst, J. M., Wienker, T. F., Sendtner, M., Rudnik-Schoneborn, S., Zerres, K., & Hubner, C. (2001). Mutations in the gene encoding immunoglobulin mu-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1. Nature Genetics, 29(1), 75\u201377.","journal-title":"Nature Genetics"},{"issue":"6","key":"162_CR108","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/ana.10755","volume":"54","author":"K Grohmann","year":"2003","unstructured":"Grohmann, K., Varon, R., Stolz, P., Schuelke, M., Janetzki, C., Bertini, E., Bushby, K., Muntoni, F., Ouvrier, R., Van Maldergem, L., Goemans, N. M., Lochmuller, H., Eichholz, S., Adams, C., Bosch, F., Grattan-Smith, P., Navarro, C., Neitzel, H., Polster, T., \u2026 Hubner, C. (2003). Infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1). Annals of Neurology, 54(6), 719\u2013724. (IN FILE).","journal-title":"Annals of Neurology"},{"issue":"5","key":"162_CR109","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1086\/302636","volume":"65","author":"K Grohmann","year":"1999","unstructured":"Grohmann, K., Wienker, T. F., Saar, K., Rudnik-Schoneborn, S., Stoltenburg-Didinger, G., Rossi, R., Novelli, G., Nurnberg, G., Pfeufer, A., Wirth, B., Reis, A., Zerres, K., & Hubner, C. (1999). Diaphragmatic spinal muscular atrophy with respiratory distress is heterogeneous, and one form Is linked to chromosome 11q13-q21. American Journal of Human Genetics, 65(5), 1459\u20131462.","journal-title":"American Journal of Human Genetics"},{"issue":"1","key":"162_CR110","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/s41467-017-00911-y","volume":"8","author":"W Guo","year":"2017","unstructured":"Guo, W., Naujock, M., Fumagalli, L., Vandoorne, T., Baatsen, P., Boon, R., Ordovas, L., Patel, A., Welters, M., Vanwelden, T., Geens, N., Tricot, T., Benoy, V., Steyaert, J., Lefebvre-Omar, C., Boesmans, W., Jarpe, M., Sterneckert, J., Wegner, F., \u2026 Van Den Bosch, L. (2017). HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients. Nature Communications, 8(1), 861. https:\/\/doi.org\/10.1038\/s41467-017-00911-y","journal-title":"Nature Communications"},{"issue":"4","key":"162_CR111","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S1474-4422(20)30037-5","volume":"19","author":"T Hagenacker","year":"2020","unstructured":"Hagenacker, T., Wurster, C. D., Gunther, R., Schreiber-Katz, O., Osmanovic, A., Petri, S., Weiler, M., Ziegler, A., Kuttler, J., Koch, J. C., Schneider, I., Wunderlich, G., Schloss, N., Lehmann, H. C., Cordts, I., Deschauer, M., Lingor, P., Kamm, C., Stolte, B., \u2026 Kleinschnitz, C. (2020). Nusinersen in adults with 5q spinal muscular atrophy: A non-interventional, multicentre, observational cohort study. Lancet Neurology, 19(4), 317\u2013325. https:\/\/doi.org\/10.1016\/S1474-4422(20)30037-5","journal-title":"Lancet Neurology"},{"issue":"1","key":"162_CR112","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.molmed.2012.11.002","volume":"19","author":"G Hamilton","year":"2013","unstructured":"Hamilton, G., & Gillingwater, T. H. (2013). Spinal muscular atrophy: Going beyond the motor neuron [Review]. Trends in Molecular Medicine, 19(1), 40\u201350. https:\/\/doi.org\/10.1016\/j.molmed.2012.11.002","journal-title":"Trends in Molecular Medicine"},{"issue":"15","key":"162_CR113","doi-asserted-by":"publisher","first-page":"5074","DOI":"10.1523\/JNEUROSCI.5808-11.2012","volume":"32","author":"T le Hao","year":"2012","unstructured":"le Hao, T., Wolman, M., Granato, M., & Beattie, C. E. (2012). Survival motor neuron affects plastin 3 protein levels leading to motor defects. Journal of Neuroscience, 32(15), 5074\u20135084. https:\/\/doi.org\/10.1523\/JNEUROSCI.5808-11.2012","journal-title":"Journal of Neuroscience"},{"issue":"2","key":"162_CR114","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.ydbio.2012.05.037","volume":"368","author":"M Hayhurst","year":"2012","unstructured":"Hayhurst, M., Wagner, A. K., Cerletti, M., Wagers, A. J., & Rubin, L. L. (2012). A cell-autonomous defect in skeletal muscle satellite cells expressing low levels of survival of motor neuron protein. Developmental Biology, 368(2), 323\u2013334. https:\/\/doi.org\/10.1016\/j.ydbio.2012.05.037","journal-title":"Developmental Biology"},{"key":"162_CR115","doi-asserted-by":"crossref","unstructured":"Heckman, C. J. & Enoka, R. M. (2004). Physiology of the motor neuron and the motor unit, clinical neurophysiology of motor neuron diseases. In Handbook of clinical neurophysiology, Vol. 4, Chapter 6.","DOI":"10.1016\/S1567-4231(04)04006-7"},{"key":"162_CR116","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1126\/science.7973664","volume":"266","author":"CE Henderson","year":"1994","unstructured":"Henderson, C. E., Phillips, H. S., Pollock, R. A., Davies, A. M., Lemeulle, C., Armanini, M., Simpson, L. C., Moffet, B., Vandlen, R. A., Koliatsos, V. E., & Rosenthal, A. (1994). GDNF: A potent survival factor for motoneurons present in peripheral nerve and muscle. Science, 266, 1062\u20131064.","journal-title":"Science"},{"key":"162_CR117","doi-asserted-by":"publisher","unstructured":"High-dose AAV gene therapy deaths. (2020, 2020\/08\/01). Nature Biotechnology, 38(8), 910. https:\/\/doi.org\/10.1038\/s41587-020-0642-9","DOI":"10.1038\/s41587-020-0642-9"},{"issue":"43","key":"162_CR118","doi-asserted-by":"publisher","first-page":"40735","DOI":"10.1074\/jbc.M206379200","volume":"277","author":"JJ Hill","year":"2002","unstructured":"Hill, J. J., Davies, M. V., Pearson, A. A., Wang, J. H., Hewick, R. M., Wolfman, N. M., & Qiu, Y. (2002). The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum. Journal of Biological Chemistry, 277(43), 40735\u201340741. https:\/\/doi.org\/10.1074\/jbc.M206379200","journal-title":"Journal of Biological Chemistry"},{"key":"162_CR119","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-021-00811-2","author":"V Himic","year":"2021","unstructured":"Himic, V., & Davies, K. E. (2021). Evaluating the potential of novel genetic approaches for the treatment of Duchenne muscular dystrophy. European Journal of Human Genetics. https:\/\/doi.org\/10.1038\/s41431-021-00811-2","journal-title":"European Journal of Human Genetics"},{"issue":"10","key":"162_CR120","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1002\/acn3.51165","volume":"7","author":"C Hinderer","year":"2020","unstructured":"Hinderer, C., Miller, R., Dyer, C., Johansson, J., Bell, P., Buza, E., & Wilson, J. M. (2020). Adeno-associated virus serotype 1-based gene therapy for FTD caused by GRN mutations. Annals of Clinical Translational Neurology, 7(10), 1843\u20131853. https:\/\/doi.org\/10.1002\/acn3.51165","journal-title":"Annals of Clinical Translational Neurology"},{"issue":"12","key":"162_CR121","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1038\/nsmb.2163","volume":"18","author":"JI Hoell","year":"2011","unstructured":"Hoell, J. I., Larsson, E., Runge, S., Nusbaum, J. D., Duggimpudi, S., Farazi, T. A., Hafner, M., Borkhardt, A., Sander, C., & Tuschl, T. (2011). RNA targets of wild-type and mutant FET family proteins [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov\u2019t]. Nature Structural & Molecular Biology, 18(12), 1428\u20131431. https:\/\/doi.org\/10.1038\/nsmb.2163","journal-title":"Nature Structural & Molecular Biology"},{"key":"162_CR122","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/BF01668496","volume":"3","author":"J Hoffmann","year":"1893","unstructured":"Hoffmann, J. (1893). Ueber chronische spinal Muskelatrophie im Kindesalter, auf famili\u00e4rer Basis. Deutsche Zeitschrift f\u00fcr Nervenheilkunde, 3, 427.","journal-title":"Deutsche Zeitschrift f\u00fcr Nervenheilkunde"},{"key":"162_CR123","first-page":"13","volume":"10","author":"J Hoffmann","year":"1897","unstructured":"Hoffmann, J. (1897). Weiterer Beitrag zur Lehre von der heredit\u00e4ren progressiven spinalen Muskelatrophie im Kindesalter. Deutsche Zeitschrift f\u00fcr Nervenheilkunde, 10, 13.","journal-title":"Deutsche Zeitschrift f\u00fcr Nervenheilkunde"},{"issue":"3","key":"162_CR124","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.ajhg.2016.07.014","volume":"99","author":"S Hosseinibarkooie","year":"2016","unstructured":"Hosseinibarkooie, S., Peters, M., Torres-Benito, L., Rastetter, R. H., Hupperich, K., Hoffmann, A., Mendoza-Ferreira, N., Kaczmarek, A., Janzen, E., Milbradt, J., Lamkemeyer, T., Rigo, F., Bennett, C. F., Guschlbauer, C., Buschges, A., Hammerschmidt, M., Riessland, M., Kye, M. J., Clemen, C. S., & Wirth, B. (2016). The power of human protective modifiers: PLS3 and CORO1C unravel impaired endocytosis in spinal muscular atrophy and rescue SMA phenotype. The American Journal of Human Genetics, 99(3), 647\u2013665.","journal-title":"The American Journal of Human Genetics"},{"issue":"11","key":"162_CR125","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1007\/s40265-019-01162-5","volume":"79","author":"SM Hoy","year":"2019","unstructured":"Hoy, S. M. (2019). Onasemnogene Abeparvovec: First global approval [review]. Drugs, 79(11), 1255\u20131262. https:\/\/doi.org\/10.1007\/s40265-019-01162-5","journal-title":"Drugs"},{"issue":"1","key":"162_CR126","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/71709","volume":"24","author":"HM Hsieh-Li","year":"2000","unstructured":"Hsieh-Li, H. M., Chang, J. G., Jong, Y. J., Wu, M. H., Wang, N. M., Tsai, C. H., & Li, H. (2000). A mouse model for spinal muscular atrophy. Nature Genetics, 24(1), 66\u201370.","journal-title":"Nature Genetics"},{"key":"162_CR127","doi-asserted-by":"crossref","unstructured":"Hua, Y., Sahashi, K., Rigo, F., Hung, G., Horev, G., Bennett, C. F., & Krainer, A. R. (2011). Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model. Nature 377(6547), 340\u2013344, 478(7367), 123\u2013126.","DOI":"10.1038\/nature10485"},{"issue":"4","key":"162_CR128","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.ajhg.2008.01.014","volume":"82","author":"Y Hua","year":"2008","unstructured":"Hua, Y., Vickers, T. A., Okunola, H. L., Bennett, C. F., & Krainer, A. R. (2008). Antisense masking of an hnRNP A1\/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov\u2019t]. The American Journal of Human Genetics, 82(4), 834\u2013848. https:\/\/doi.org\/10.1016\/j.ajhg.2008.01.014","journal-title":"The American Journal of Human Genetics"},{"key":"162_CR129","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/0896-6273(93)90327-N","volume":"10","author":"RA Hughes","year":"1993","unstructured":"Hughes, R. A., Sendtner, M., Goldfarb, M., Lindholm, D., & Thoenen, H. (1993). Evidence that fibroblast growth factor 5 is a major muscle derived survival factor for cultured spinal motoneurons. Neuron, 10, 369\u2013377. (IN FILE).","journal-title":"Neuron"},{"issue":"1","key":"162_CR130","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1124\/jpet.114.222224","volume":"353","author":"DT Hwee","year":"2015","unstructured":"Hwee, D. T., Kennedy, A. R., Hartman, J. J., Ryans, J., Durham, N., Malik, F. I., & Jasper, J. R. (2015). The small-molecule fast skeletal troponin activator, CK-2127107, improves exercise tolerance in a rat model of heart failure [Research Support, Non-U.S. Gov\u2019t]. Journal of Pharmacology and Experimental Therapeutics, 353(1), 159\u2013168. https:\/\/doi.org\/10.1124\/jpet.114.222224","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"3","key":"162_CR131","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/ng1196-285","volume":"14","author":"G Imbert","year":"1996","unstructured":"Imbert, G., Saudou, F., Yvert, G., Devys, D., Trottier, Y., Garnier, J. M., Weber, C., Mandel, J. L., Cancel, G., Abbas, N., Durr, A., Didierjean, O., Stevanin, G., Agid, Y., & Brice, A. (1996). Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG\/glutamine repeats. Nature Genetics, 14(3), 285\u2013291. https:\/\/doi.org\/10.1038\/ng1196-285","journal-title":"Nature Genetics"},{"key":"162_CR132","doi-asserted-by":"crossref","unstructured":"Imlach, W. L., Beck, E. S., Choi, B. J., Lotti, F., Pellizzoni, L., & McCabe, B. D. (2012). SMN is required for sensory-motor circuit function in Drosophila. Cell 77(5), 727\u2013736, 151(2), 427\u2013439.","DOI":"10.1016\/j.cell.2012.09.011"},{"issue":"1","key":"162_CR133","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nrneurol.2015.225","volume":"12","author":"K Iqbal","year":"2016","unstructured":"Iqbal, K., Liu, F., & Gong, C. X. (2016). Tau and neurodegenerative disease: The story so far [Review]. Nature Reviews. Neurology, 12(1), 15\u201327. https:\/\/doi.org\/10.1038\/nrneurol.2015.225","journal-title":"Nature Reviews. Neurology"},{"issue":"5","key":"162_CR134","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.celrep.2017.01.013","volume":"18","author":"S Ishigaki","year":"2017","unstructured":"Ishigaki, S., Fujioka, Y., Okada, Y., Riku, Y., Udagawa, T., Honda, D., Yokoi, S., Endo, K., Ikenaka, K., Takagi, S., Iguchi, Y., Sahara, N., Takashima, A., Okano, H., Yoshida, M., Warita, H., Aoki, M., Watanabe, H., Okado, H., \u2026 Sobue, G. (2017). Altered Tau isoform ratio caused by loss of FUS and SFPQ function leads to FTLD-like phenotypes. Cell Reports, 18(5), 1118\u20131131. https:\/\/doi.org\/10.1016\/j.celrep.2017.01.013","journal-title":"Cell Reports"},{"key":"162_CR135","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/srep00529","volume":"2","author":"S Ishigaki","year":"2012","unstructured":"Ishigaki, S., Masuda, A., Fujioka, Y., Iguchi, Y., Katsuno, M., Shibata, A., Urano, F., Sobue, G., & Ohno, K. (2012). Position-dependent FUS-RNA interactions regulate alternative splicing events and transcriptions [Research Support, Non-U.S. Gov\u2019t]. Scientific Reports, 2, 529. https:\/\/doi.org\/10.1038\/srep00529","journal-title":"Scientific Reports"},{"issue":"3","key":"162_CR136","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00401-020-02191-1","volume":"140","author":"A Ittner","year":"2020","unstructured":"Ittner, A., Asih, P. R., Tan, A. R. P., Prikas, E., Bertz, J., Stefanoska, K., Lin, Y., Volkerling, A. M., Ke, Y. D., Delerue, F., & Ittner, L. M. (2020). Reduction of advanced tau-mediated memory deficits by the MAP kinase p38gamma [Research Support, Non-US Gov\u2019t]. Acta Neuropathologica, 140(3), 279\u2013294. https:\/\/doi.org\/10.1007\/s00401-020-02191-1","journal-title":"Acta Neuropathologica"},{"issue":"21","key":"162_CR137","doi-asserted-by":"publisher","first-page":"6160","DOI":"10.1093\/hmg\/ddv332","volume":"24","author":"CC Iyer","year":"2015","unstructured":"Iyer, C. C., McGovern, V. L., Murray, J. D., Gombash, S. E., Zaworski, P. G., Foust, K. D., Janssen, P. M., & Burghes, A. H. (2015). Low levels of Survival Motor Neuron protein are sufficient for normal muscle function in the SMNDelta7 mouse model of SMA. Human Molecular Genetics, 24(21), 6160\u20136173. https:\/\/doi.org\/10.1093\/hmg\/ddv332","journal-title":"Human Molecular Genetics"},{"issue":"5","key":"162_CR138","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1093\/hmg\/10.5.497","volume":"10","author":"S Jablonka","year":"2001","unstructured":"Jablonka, S., Bandilla, M., Wiese, S., Buhler, D., Wirth, B., Sendtner, M., & Fischer, U. (2001). Co-regulation of survival of motor neuron (SMN) protein and its interactor SIP1 during development and in spinal muscular atrophy. Human Molecular Genetics, 10(5), 497\u2013505. https:\/\/doi.org\/10.1093\/hmg\/10.5.497","journal-title":"Human Molecular Genetics"},{"issue":"1","key":"162_CR139","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1083\/jcb.200703187","volume":"179","author":"S Jablonka","year":"2007","unstructured":"Jablonka, S., Beck, M., Lechner, B. D., Mayer, C., & Sendtner, M. (2007). Defective Ca2+ channel clustering in axon terminals disturbs excitability in motoneurons in spinal muscular atrophy. Journal of Cell Biology, 179(1), 139\u2013149. (IN FILE).","journal-title":"Journal of Cell Biology"},{"issue":"3","key":"162_CR140","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/hmg\/9.3.341","volume":"9","author":"S Jablonka","year":"2000","unstructured":"Jablonka, S., Schrank, B., Kralewski, M., Rossoll, W., & Sendtner, M. (2000). Reduced survival motor neuron (Smn) gene dose in mice leads to motor neuron degeneration: an animal model for spinal muscular atrophy type III [Research Support, Non-U.S. Gov\u2019t]. Human Molecular Genetics, 9(3), 341\u2013346. https:\/\/doi.org\/10.1093\/hmg\/9.3.341","journal-title":"Human Molecular Genetics"},{"key":"162_CR141","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2017.46","author":"S Jablonka","year":"2017","unstructured":"Jablonka, S., & Sendtner, M. (2017). Developmental regulation of SMN expression: Pathophysiological implications and perspectives for therapy development in spinal muscular atrophy [Review]. Gene Therapy. https:\/\/doi.org\/10.1038\/gt.2017.46","journal-title":"Gene Therapy"},{"issue":"2","key":"162_CR142","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/neu.10313","volume":"58","author":"S Jablonka","year":"2004","unstructured":"Jablonka, S., Wiese, S., & Sendtner, M. (2004). Axonal defects in mouse models of motoneuron disease. Journal of Neurobiology, 58(2), 272\u2013286.","journal-title":"Journal of Neurobiology"},{"issue":"8","key":"162_CR143","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1093\/brain\/awy167","volume":"141","author":"E Janzen","year":"2018","unstructured":"Janzen, E., Mendoza-Ferreira, N., Hosseinibarkooie, S., Schneider, S., Hupperich, K., Tschanz, T., Grysko, V., Riessland, M., Hammerschmidt, M., Rigo, F., Bennett, C. F., Kye, M. J., Torres-Benito, L., & Wirth, B. (2018). CHP1 reduction ameliorates spinal muscular atrophy pathology by restoring calcineurin activity and endocytosis [Research Support, Non-U.S. Gov\u2019t]. Brain, 141(8), 2343\u20132361. https:\/\/doi.org\/10.1093\/brain\/awy167","journal-title":"Brain"},{"issue":"1","key":"162_CR144","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1038\/s41467-021-21529-1","volume":"12","author":"C Ji","year":"2021","unstructured":"Ji, C., Bader, J., Ramanathan, P., Hennlein, L., Meissner, F., Jablonka, S., Mann, M., Fischer, U., Sendtner, M., & Briese, M. (2021). Interaction of 7SK with the Smn complex modulates snRNP production [Research Support, Non-U.S. Gov\u2019t]. Nature Communications, 12(1), 1278. https:\/\/doi.org\/10.1038\/s41467-021-21529-1","journal-title":"Nature Communications"},{"key":"162_CR145","doi-asserted-by":"publisher","first-page":"12143","DOI":"10.1038\/ncomms12143","volume":"7","author":"K Kapeli","year":"2016","unstructured":"Kapeli, K., Pratt, G. A., Vu, A. Q., Hutt, K. R., Martinez, F. J., Sundararaman, B., Batra, R., Freese, P., Lambert, N. J., Huelga, S. C., Chun, S. J., Liang, T. Y., Chang, J., Donohue, J. P., Shiue, L., Zhang, J., Zhu, H., Cambi, F., Kasarskis, E., \u2026 Yeo, G. W. (2016). Distinct and shared functions of ALS-associated proteins TDP-43, FUS and TAF15 revealed by multisystem analyses [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov\u2019t]. Nature Communications, 7, 12143. https:\/\/doi.org\/10.1038\/ncomms12143","journal-title":"Nature Communications"},{"issue":"9579","key":"162_CR146","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1016\/S0140-6736(07)60982-9","volume":"369","author":"MG Kaplitt","year":"2007","unstructured":"Kaplitt, M. G., Feigin, A., Tang, C., Fitzsimons, H. L., Mattis, P., Lawlor, P. A., Bland, R. J., Young, D., Strybing, K., Eidelberg, D., & During, M. J. (2007). Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson\u2019s disease: an open label, phase I trial [Clinical Trial, Phase I Research Support, Non-U.S. Gov\u2019t]. Lancet, 369(9579), 2097\u20132105. https:\/\/doi.org\/10.1016\/S0140-6736(07)60982-9","journal-title":"Lancet"},{"issue":"2","key":"162_CR147","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1172\/JCI72017","volume":"124","author":"S Kariya","year":"2014","unstructured":"Kariya, S., Obis, T., Garone, C., Akay, T., Sera, F., Iwata, S., Homma, S., & Monani, U. R. (2014). Requirement of enhanced Survival Motoneuron protein imposed during neuromuscular junction maturation [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov\u2019t Research Support, U.S. Gov\u2019t, Non-P.H.S.]. Journal of Clinical Investigation, 124(2), 785\u2013800. https:\/\/doi.org\/10.1172\/JCI72017","journal-title":"Journal of Clinical Investigation"},{"key":"162_CR148","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1006\/exnr.1994.1198","volume":"130","author":"AC Kato","year":"1994","unstructured":"Kato, A. C., & Lindsay, R. M. (1994). Overlapping and additive effects of neurotrophins and CNTF on cultured human spinal cord neurons. Experimental Neurology, 130, 196\u2013201.","journal-title":"Experimental Neurology"},{"issue":"9","key":"162_CR149","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1093\/hmg\/ddi130","volume":"14","author":"LE Kernochan","year":"2005","unstructured":"Kernochan, L. E., Russo, M. L., Woodling, N. S., Huynh, T. N., Avila, A. M., Fischbeck, K. H., & Sumner, C. J. (2005). The role of histone acetylation in SMN gene expression. Human Molecular Genetics, 14(9), 1171\u20131182.","journal-title":"Human Molecular Genetics"},{"issue":"5","key":"162_CR150","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.neuron.2020.08.022","volume":"108","author":"G Kim","year":"2020","unstructured":"Kim, G., Gautier, O., Tassoni-Tsuchida, E., Ma, X. R., & Gitler, A. D. (2020). ALS genetics: Gains, losses, and implications for future therapies [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov\u2019t Research Support, U.S. Gov\u2019t, Non-P.H.S. Review]. Neuron, 108(5), 822\u2013842. https:\/\/doi.org\/10.1016\/j.neuron.2020.08.022","journal-title":"Neuron"},{"issue":"3","key":"162_CR151","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1172\/JCI131989","volume":"130","author":"JK Kim","year":"2020","unstructured":"Kim, J. K., Jha, N. N., Feng, Z., Faleiro, M. R., Chiriboga, C. A., Wei-Lapierre, L., Dirksen, R. T., Ko, C. P., & Monani, U. R. (2020). Muscle-specific SMN reduction reveals motor neuron-independent disease in spinal muscular atrophy models. The Journal of Clinical Investigation, 130(3), 1271\u20131287. https:\/\/doi.org\/10.1172\/JCI131989","journal-title":"The Journal of Clinical Investigation"},{"key":"162_CR152","doi-asserted-by":"crossref","unstructured":"Klein, R., Jing, S., Nanduri, V., O'Rourke, E., & Barbacid, M. (1991). The trk proto-oncogene encodes a receptor for nerve growth factor. Cell 77(5), 727\u2013736, 65, 189\u2013197.","DOI":"10.1016\/0092-8674(91)90419-Y"},{"key":"162_CR153","doi-asserted-by":"crossref","unstructured":"Klein, R., Nanduri, V., Jing, S., Lamballe, F., Tapley, P., Bryant, S., Cordon-Cardo, C., Jones, K. R., Reichardt, L. F., & Barbacid, M. (1991). The trk B tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3. Cell 77(5), 727\u2013736, 66, 395\u2013403.","DOI":"10.1016\/0092-8674(91)90628-C"},{"key":"162_CR154","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.1002\/j.1460-2075.1989.tb08545.x","volume":"8","author":"R Klein","year":"1989","unstructured":"Klein, R., Parada, L. F., Coulier, F., & Barbacid, M. (1989). trk B, a novel tyrosine protein kinase receptor expressed during mouse neural development. EMBO Journal, 8, 3701\u20133709. (IN FILE).","journal-title":"EMBO Journal"},{"issue":"4","key":"162_CR155","first-page":"498","volume":"45","author":"M Koenig","year":"1989","unstructured":"Koenig, M., Beggs, A. H., Moyer, M., Scherpf, S., Heindrich, K., Bettecken, T., Meng, G., Muller, C. R., Lindlof, M., Kaariainen, H., de la Chapellet, A., Kiuru, A., Savontaus, M. L., Gilgenkrantz, H., Recan, D., Chelly, J., Kaplan, J. C., Covone, A. E., Archidiacono, N., \u2026 Kunkel, L. M. (1989). The molecular basis for Duchenne versus Becker muscular dystrophy: Correlation of severity with type of deletion. American Journal of Human Genetics, 45(4), 498\u2013506.","journal-title":"American Journal of Human Genetics"},{"key":"162_CR156","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abb6871","author":"L Kong","year":"2021","unstructured":"Kong, L., Valdivia, D. O., Simon, C. M., Hassinan, C. W., Delestree, N., Ramos, D. M., Park, J. H., Pilato, C. M., Xu, X., Crowder, M., Grzyb, C. C., King, Z. A., Petrillo, M., Swoboda, K. J., Davis, C., Lutz, C. M., Stephan, A. H., Zhao, X., Weetall, M., \u2026 Sumner, C. J. (2021). Impaired prenatal motor axon development necessitates early therapeutic intervention in severe SMA. Science Translational Medicine. https:\/\/doi.org\/10.1126\/scitranslmed.abb6871","journal-title":"Science Translational Medicine"},{"issue":"3","key":"162_CR157","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1523\/JNEUROSCI.4434-08.2009","volume":"29","author":"L Kong","year":"2009","unstructured":"Kong, L., Wang, X., Choe, D. W., Polley, M., Burnett, B. G., Bosch-Marce, M., Griffin, J. W., Rich, M. M., & Sumner, C. J. (2009). Impaired synaptic vesicle release and immaturity of neuromuscular junctions in spinal muscular atrophy mice. Journal of Neuroscience, 29(3), 842\u2013851.","journal-title":"Journal of Neuroscience"},{"key":"162_CR158","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.nbd.2012.12.010","volume":"54","author":"F Krieger","year":"2013","unstructured":"Krieger, F., Elflein, N., Ruiz, R., Guerra, J., Serrano, A. L., Asan, E., Tabares, L., & Jablonka, S. (2013). Fast motor axon loss in SMARD1 does not correspond to morphological and functional alterations of the NMJ. Neurobiology of Disease, 54, 169\u2013182.","journal-title":"Neurobiology of Disease"},{"issue":"Pt 5","key":"162_CR159","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1093\/brain\/awu059","volume":"137","author":"F Krieger","year":"2014","unstructured":"Krieger, F., Elflein, N., Saenger, S., Wirthgen, E., Rak, K., Frantz, S., Hoeflich, A., Toyka, K. V., Metzger, F., & Jablonka, S. (2014). Polyethylene glycol-coupled IGF1 delays motor function defects in a mouse model of spinal muscular atrophy with respiratory distress type 1. Brain, 137(Pt 5), 1374\u20131393.","journal-title":"Brain"},{"key":"162_CR160","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1001\/archneurpsyc.1956.02330230050005","volume":"75","author":"E Kugelberg","year":"1956","unstructured":"Kugelberg, E., & Welander, L. (1956). Heredofamilial juvenile muscular atrophy simulating muscular dystrophy. Archives of Neurology, 75, 500.","journal-title":"Archives of Neurology"},{"key":"162_CR161","doi-asserted-by":"publisher","first-page":"711","DOI":"10.3389\/fnins.2017.00711","volume":"11","author":"V Kumar","year":"2017","unstructured":"Kumar, V., Hasan, G. M., & Hassan, M. I. (2017). Unraveling the role of RNA mediated toxicity of C9orf72 repeats in C9-FTD\/ALS [Review]. Frontiers in Neuroscience, 11, 711. https:\/\/doi.org\/10.3389\/fnins.2017.00711","journal-title":"Frontiers in Neuroscience"},{"issue":"5918","key":"162_CR162","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1126\/science.1166066","volume":"323","author":"TJ Kwiatkowski Jr","year":"2009","unstructured":"Kwiatkowski, T. J., Jr., Bosco, D. A., Leclerc, A. L., Tamrazian, E., Vanderburg, C. R., Russ, C., Davis, A., Gilchrist, J., Kasarskis, E. J., Munsat, T., Valdmanis, P., Rouleau, G. A., Hosler, B. A., Cortelli, P., de Jong, P. J., Yoshinaga, Y., Haines, J. L., Pericak-Vance, M. A., Yan, J., \u2026 Brown, R. H., Jr. (2009). Mutations in the FUS\/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science, 323(5918), 1205\u20131208. https:\/\/doi.org\/10.1126\/science.1166066","journal-title":"Science"},{"issue":"6201","key":"162_CR163","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1126\/science.1254917","volume":"345","author":"I Kwon","year":"2014","unstructured":"Kwon, I., Xiang, S., Kato, M., Wu, L., Theodoropoulos, P., Wang, T., Kim, J., Yun, J., Xie, Y., & McKnight, S. L. (2014). Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells [Research Support, Non-U.S. Gov\u2019t]. Science, 345(6201), 1139\u20131145. https:\/\/doi.org\/10.1126\/science.1254917","journal-title":"Science"},{"issue":"11","key":"162_CR164","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1038\/nn.3230","volume":"15","author":"C Lagier-Tourenne","year":"2012","unstructured":"Lagier-Tourenne, C., Polymenidou, M., Hutt, K. R., Vu, A. Q., Baughn, M., Huelga, S. C., Clutario, K. M., Ling, S. C., Liang, T. Y., Mazur, C., Wancewicz, E., Kim, A. S., Watt, A., Freier, S., Hicks, G. G., Donohue, J. P., Shiue, L., Bennett, C. F., Ravits, J., \u2026 Yeo, G. W. (2012). Divergent roles of ALS-linked proteins FUS\/TLS and TDP-43 intersect in processing long pre-mRNAs [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov\u2019t Research Support, U.S. Gov\u2019t, Non-P.H.S.]. Nature Neurosciences, 15(11), 1488\u20131497. https:\/\/doi.org\/10.1038\/nn.3230","journal-title":"Nature Neurosciences"},{"key":"162_CR165","doi-asserted-by":"publisher","first-page":"16105","DOI":"10.1038\/ncomms16105","volume":"8","author":"C Le Guiner","year":"2017","unstructured":"Le Guiner, C., Servais, L., Montus, M., Larcher, T., Fraysse, B., Moullec, S., Allais, M., Francois, V., Dutilleul, M., Malerba, A., Koo, T., Thibaut, J. L., Matot, B., Devaux, M., Le Duff, J., Deschamps, J. Y., Barthelemy, I., Blot, S., Testault, I., \u2026 Dickson, G. (2017). Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy [Research Support, Non-U.S. Gov\u2019t]. Nature Communications, 8, 16105. https:\/\/doi.org\/10.1038\/ncomms16105","journal-title":"Nature Communications"},{"issue":"6","key":"162_CR166","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1093\/hmg\/ddi078","volume":"14","author":"TT Le","year":"2005","unstructured":"Le, T. T., Pham, L. T., Butchbach, M. E., Zhang, H. L., Monani, U. R., Coovert, D. D., Gavrilina, T. O., Xing, L., Bassell, G. J., & Burghes, A. H. (2005). SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN. Human Molecular Genetics, 14(6), 845\u2013857.","journal-title":"Human Molecular Genetics"},{"issue":"5","key":"162_CR167","doi-asserted-by":"publisher","first-page":"e0197084","DOI":"10.1371\/journal.pone.0197084","volume":"13","author":"J Lee","year":"2018","unstructured":"Lee, J., Echigoya, Y., Duddy, W., Saito, T., Aoki, Y., Takeda, S., & Yokota, T. (2018). Antisense PMO cocktails effectively skip dystrophin exons 45\u201355 in myotubes transdifferentiated from DMD patient fibroblasts [Research Support, Non-U.S. Gov\u2019t]. PLoS ONE, 13(5), e0197084. https:\/\/doi.org\/10.1371\/journal.pone.0197084","journal-title":"PLoS ONE"},{"issue":"3","key":"162_CR168","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.cell.2016.10.002","volume":"167","author":"KH Lee","year":"2016","unstructured":"Lee, K. H., Zhang, P., Kim, H. J., Mitrea, D. M., Sarkar, M., Freibaum, B. D., Cika, J., Coughlin, M., Messing, J., Molliex, A., Maxwell, B. A., Kim, N. C., Temirov, J., Moore, J., Kolaitis, R. M., Shaw, T. I., Bai, B., Peng, J., Kriwacki, R. W., & Taylor, J. P. (2016). C9orf72 dipeptide repeats impair the assembly, dynamics, and function of membrane-less organelles [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov\u2019t]. Cell, 167(3), 774\u2013788717. https:\/\/doi.org\/10.1016\/j.cell.2016.10.002","journal-title":"Cell"},{"issue":"16","key":"162_CR169","doi-asserted-by":"publisher","first-page":"9306","DOI":"10.1073\/pnas.151270098","volume":"98","author":"SJ Lee","year":"2001","unstructured":"Lee, S. J., & McPherron, A. C. (2001). Regulation of myostatin activity and muscle growth. Proceedings of the National Academy of Sciences USA, 98(16), 9306\u20139311. https:\/\/doi.org\/10.1073\/pnas.151270098","journal-title":"Proceedings of the National Academy of Sciences USA"},{"key":"162_CR170","doi-asserted-by":"crossref","unstructured":"Lefebvre, S., Burglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L., Benichou, B., Cruaud, C., Millasseau, P., Zeviani, M., & et al. (1995). Identification and characterization of a spinal muscular atrophy- determining gene [see comments]. Cell 77(5), 727\u201336, 80(1), 155\u2013165.","DOI":"10.1016\/0092-8674(95)90460-3"},{"issue":"4","key":"162_CR171","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S1474-4422(11)70039-4","volume":"10","author":"PA LeWitt","year":"2011","unstructured":"LeWitt, P. A., Rezai, A. R., Leehey, M. A., Ojemann, S. G., Flaherty, A. W., Eskandar, E. N., Kostyk, S. K., Thomas, K., Sarkar, A., Siddiqui, M. S., Tatter, S. B., Schwalb, J. M., Poston, K. L., Henderson, J. M., Kurlan, R. M., Richard, I. H., Van Meter, L., Sapan, C. V., During, M. J., \u2026 Feigin, A. (2011). AAV2-GAD gene therapy for advanced Parkinson\u2019s disease: A double-blind, sham-surgery controlled, randomised trial [Randomized Controlled Trial Research Support, Non-U.S. Gov\u2019t]. The Lancet Neurology, 10(4), 309\u2013319. https:\/\/doi.org\/10.1016\/S1474-4422(11)70039-4","journal-title":"The Lancet Neurology"},{"key":"162_CR172","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/neu.480250702","volume":"25","author":"L Li","year":"1994","unstructured":"Li, L., Oppenheim, R. W., Lei, M., & Houenou, L. J. (1994). Neurotrophic agents prevent motoneuron death following sciatic nerve section in the neonatal mouse. Journal of Neurobiology, 25, 759\u2013766. (IN FILE).","journal-title":"Journal of Neurobiology"},{"issue":"2","key":"162_CR173","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/s0896-6273(00)80893-4","volume":"25","author":"JW Lichtman","year":"2000","unstructured":"Lichtman, J. W., & Colman, H. (2000). Synapse elimination and indelible memory. Neuron, 25(2), 269\u2013278. https:\/\/doi.org\/10.1016\/s0896-6273(00)80893-4","journal-title":"Neuron"},{"issue":"1","key":"162_CR174","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/hmg\/ddr453","volume":"21","author":"KK Ling","year":"2012","unstructured":"Ling, K. K., Gibbs, R. M., Feng, Z., & Ko, C. P. (2012). Severe neuromuscular denervation of clinically relevant muscles in a mouse model of spinal muscular atrophy. Human Molecular Genetics, 21(1), 185\u2013195.","journal-title":"Human Molecular Genetics"},{"key":"162_CR175","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1469-7793.1997.129bi.x","volume":"503","author":"JC Liou","year":"1997","unstructured":"Liou, J. C., Yang, R. S., & Fu, W. M. (1997). Regulation of quantal secretion by neurotrophic factors at developing motoneurons in xenopus cell cultures. Journal of Physiology (London), 503, 129\u2013139.","journal-title":"Journal of Physiology (London)"},{"key":"162_CR176","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1002\/j.1460-2075.1996.tb00725.x","volume":"15","author":"Q Liu","year":"1996","unstructured":"Liu, Q., & Dreyfuss, G. (1996). A novel nuclear structure containing the survival of motor neurons protein. EMBO Journal, 15, 3555\u20133565.","journal-title":"EMBO Journal"},{"key":"162_CR177","doi-asserted-by":"crossref","unstructured":"Liu, Q., Fischer, U., Wang, F., & Dreyfuss, G. (1997). The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins. Cell 77(5), 727\u2013736, 90(6), 1013\u20131021.","DOI":"10.1016\/S0092-8674(00)80367-0"},{"issue":"5","key":"162_CR178","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s43440-020-00134-x","volume":"72","author":"A Loboda","year":"2020","unstructured":"Loboda, A., & Dulak, J. (2020). Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: Past, present, and future. Pharmacological Reports, 72(5), 1227\u20131263. https:\/\/doi.org\/10.1007\/s43440-020-00134-x","journal-title":"Pharmacological Reports"},{"issue":"7","key":"162_CR179","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1093\/hmg\/ddy382","volume":"28","author":"KK Long","year":"2019","unstructured":"Long, K. K., O\u2019Shea, K. M., Khairallah, R. J., Howell, K., Paushkin, S., Chen, K. S., Cote, S. M., Webster, M. T., Stains, J. P., Treece, E., Buckler, A., & Donovan, A. (2019). Specific inhibition of myostatin activation is beneficial in mouse models of SMA therapy. Human Molecular Genetics, 28(7), 1076\u20131089. https:\/\/doi.org\/10.1093\/hmg\/ddy382","journal-title":"Human Molecular Genetics"},{"issue":"11","key":"162_CR180","doi-asserted-by":"publisher","first-page":"6307","DOI":"10.1073\/pnas.96.11.6307","volume":"96","author":"CL Lorson","year":"1999","unstructured":"Lorson, C. L., Hahnen, E., Androphy, E. J., & Wirth, B. (1999). A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proceedings of the National academy of Sciences of the United States of America, 96(11), 6307\u20136311.","journal-title":"Proceedings of the National academy of Sciences of the United States of America"},{"issue":"2","key":"162_CR181","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.cell.2012.09.012","volume":"151","author":"F Lotti","year":"2012","unstructured":"Lotti, F., Imlach, W. L., Saieva, L., Beck, E. S., le Hao, T., Li, D. K., Jiao, W., Mentis, G. Z., Beattie, C. E., McCabe, B. D., & Pellizzoni, L. (2012). An SMN-dependent U12 splicing event essential for motor circuit function [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov\u2019t Research Support, U.S. Gov\u2019t, Non-P.H.S.]. Cell, 151(2), 440\u2013454. https:\/\/doi.org\/10.1016\/j.cell.2012.09.012","journal-title":"Cell"},{"issue":"8","key":"162_CR182","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1089\/hum.2015.070","volume":"26","author":"KE Lundin","year":"2015","unstructured":"Lundin, K. E., Gissberg, O., & Smith, C. I. (2015). Oligonucleotide therapies: The past and the present. Human Gene Therapy, 26(8), 475\u2013485. https:\/\/doi.org\/10.1089\/hum.2015.070","journal-title":"Human Gene Therapy"},{"issue":"8","key":"162_CR183","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1172\/JCI57291","volume":"121","author":"CM Lutz","year":"2011","unstructured":"Lutz, C. M., Kariya, S., Patruni, S., Osborne, M. A., Liu, D., Henderson, C. E., Li, D. K., Pellizzoni, L., Rojas, J., Valenzuela, D. M., Murphy, A. J., Winberg, M. L., & Monani, U. R. (2011). Postsymptomatic restoration of SMN rescues the disease phenotype in a mouse model of severe spinal muscular atrophy [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov\u2019t]. Journal of Clinical Investigation, 121(8), 3029\u20133041. https:\/\/doi.org\/10.1172\/JCI57291","journal-title":"Journal of Clinical Investigation"},{"issue":"11","key":"162_CR184","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1136\/jnnp-2020-323822","volume":"91","author":"L Maggi","year":"2020","unstructured":"Maggi, L., Bello, L., Bonanno, S., Govoni, A., Caponnetto, C., Passamano, L., Grandis, M., Trojsi, F., Cerri, F., Ferraro, M., Bozzoni, V., Caumo, L., Piras, R., Tanel, R., Saccani, E., Meneri, M., Vacchiano, V., Ricci, G., Soraru, G., \u2026 Pegoraro, E. (2020). Nusinersen safety and effects on motor function in adult spinal muscular atrophy type 2 and 3. Journal of Neurology, Neurosurgery and Psychiatry, 91(11), 1166\u20131174. https:\/\/doi.org\/10.1136\/jnnp-2020-323822","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"1","key":"162_CR185","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/00125817-200201000-00004","volume":"4","author":"MD Mailman","year":"2002","unstructured":"Mailman, M. D., Heinz, J. W., Papp, A. C., Snyder, P. J., Sedra, M. S., Wirth, B., Burghes, A. H., & Prior, T. W. (2002). Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2. Genetics in Medicine, 4(1), 20\u201326.","journal-title":"Genetics in Medicine"},{"issue":"6","key":"162_CR186","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/NEN.0000000000000078","volume":"73","author":"R Martinez-Hernandez","year":"2014","unstructured":"Martinez-Hernandez, R., Bernal, S., Alias, L., & Tizzano, E. F. (2014). Abnormalities in early markers of muscle involvement support a delay in myogenesis in spinal muscular atrophy. Journal of Neuropathology and Experimental Neurology, 73(6), 559\u2013567. https:\/\/doi.org\/10.1097\/NEN.0000000000000078","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"issue":"5","key":"162_CR187","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1097\/NEN.0b013e3181a10ea1","volume":"68","author":"R Martinez-Hernandez","year":"2009","unstructured":"Martinez-Hernandez, R., Soler-Botija, C., Also, E., Alias, L., Caselles, L., Gich, I., Bernal, S., & Tizzano, E. F. (2009). The developmental pattern of myotubes in spinal muscular atrophy indicates prenatal delay of muscle maturation. Journal of Neuropathology and Experimental Neurology, 68(5), 474\u2013481. https:\/\/doi.org\/10.1097\/NEN.0b013e3181a10ea1","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"issue":"10","key":"162_CR188","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1101\/gad.255737.114","volume":"29","author":"A Masuda","year":"2015","unstructured":"Masuda, A., Takeda, J., Okuno, T., Okamoto, T., Ohkawara, B., Ito, M., Ishigaki, S., Sobue, G., & Ohno, K. (2015). Position-specific binding of FUS to nascent RNA regulates mRNA length [Research Support, Non-U.S. Gov\u2019t]. Genes & Development, 29(10), 1045\u20131057. https:\/\/doi.org\/10.1101\/gad.255737.114","journal-title":"Genes & Development"},{"issue":"4","key":"162_CR189","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00401-014-1329-4","volume":"128","author":"S May","year":"2014","unstructured":"May, S., Hornburg, D., Schludi, M. H., Arzberger, T., Rentzsch, K., Schwenk, B. M., Grasser, F. A., Mori, K., Kremmer, E., Banzhaf-Strathmann, J., Mann, M., Meissner, F., & Edbauer, D. (2014). C9orf72 FTLD\/ALS-associated Gly-Ala dipeptide repeat proteins cause neuronal toxicity and Unc119 sequestration [Research Support, Non-U.S. Gov\u2019t]. Acta Neuropathologica, 128(4), 485\u2013503. https:\/\/doi.org\/10.1007\/s00401-014-1329-4","journal-title":"Acta Neuropathologica"},{"key":"162_CR190","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12740","author":"NM McCormack","year":"2021","unstructured":"McCormack, N. M., Villalon, E., Viollet, C., Soltis, A. R., Dalgard, C. L., Lorson, C. L., & Burnett, B. G. (2021). Survival motor neuron deficiency slows myoblast fusion through reduced myomaker and myomixer expression. Journal of Cachexia, Sarcopenia and Muscle. https:\/\/doi.org\/10.1002\/jcsm.12740","journal-title":"Journal of Cachexia, Sarcopenia and Muscle"},{"issue":"6628","key":"162_CR191","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/387083a0","volume":"387","author":"AC McPherron","year":"1997","unstructured":"McPherron, A. C., Lawler, A. M., & Lee, S. J. (1997). Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature, 387(6628), 83\u201390. https:\/\/doi.org\/10.1038\/387083a0","journal-title":"Nature"},{"issue":"5","key":"162_CR192","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1083\/jcb.200303168","volume":"162","author":"ML McWhorter","year":"2003","unstructured":"McWhorter, M. L., Monani, U. R., Burghes, A. H., & Beattie, C. E. (2003). Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding. Journal of Cell Biology, 162(5), 919\u2013932.","journal-title":"Journal of Cell Biology"},{"issue":"1\u20132","key":"162_CR193","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1432-1033.1997.t01-2-00527.x","volume":"243","author":"L Meijer","year":"1997","unstructured":"Meijer, L., Borgne, A., Mulner, O., Chong, J. P., Blow, J. J., Inagaki, N., Inagaki, M., Delcros, J. G., & Moulinoux, J. P. (1997). Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. European Journal of Biochemistry, 243(1\u20132), 527\u2013536.","journal-title":"European Journal of Biochemistry"},{"issue":"10","key":"162_CR194","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/S0962-8924(02)02371-1","volume":"12","author":"G Meister","year":"2002","unstructured":"Meister, G., Eggert, C., & Fischer, U. (2002). SMN-mediated assembly of RNPs: A complex story. Trends in Cell Biology, 12(10), 472\u2013478.","journal-title":"Trends in Cell Biology"},{"issue":"18","key":"162_CR195","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","volume":"377","author":"JR Mendell","year":"2017","unstructured":"Mendell, J. R., Al-Zaidy, S., Shell, R., Arnold, W. D., Rodino-Klapac, L. R., Prior, T. W., Lowes, L., Alfano, L., Berry, K., Church, K., Kissel, J. T., Nagendran, S., L\u2019Italien, J., Sproule, D. M., Wells, C., Cardenas, J. A., Heitzer, M. D., Kaspar, A., Corcoran, S., \u2026 Kaspar, B. K. (2017). Single-dose gene-replacement therapy for spinal muscular atrophy [Clinical Trial, Phase I Clinical Trial, Phase II Controlled Clinical Trial]. New England Journal of Medicine, 377(18), 1713\u20131722. https:\/\/doi.org\/10.1056\/NEJMoa1706198","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"162_CR196","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1056\/NEJMoa1710504","volume":"378","author":"E Mercuri","year":"2018","unstructured":"Mercuri, E., Darras, B. T., Chiriboga, C. A., Day, J. W., Campbell, C., Connolly, A. M., Iannaccone, S. T., Kirschner, J., Kuntz, N. L., Saito, K., Shieh, P. B., Tulinius, M., Mazzone, E. S., Montes, J., Bishop, K. M., Yang, Q., Foster, R., Gheuens, S., Bennett, C. F., \u2026 Group, C. S. (2018). Nusinersen versus Sham control in later-onset spinal muscular atrophy [Clinical Trial, Phase III Comparative Study Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov\u2019t]. New England Journal of Medicine, 378(7), 625\u2013635. https:\/\/doi.org\/10.1056\/NEJMoa1710504","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"162_CR197","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","volume":"28","author":"E Mercuri","year":"2018","unstructured":"Mercuri, E., Finkel, R. S., Muntoni, F., Wirth, B., Montes, J., Main, M., Mazzone, E. S., Vitale, M., Snyder, B., Quijano-Roy, S., Bertini, E., Davis, R. H., Meyer, O. H., Simonds, A. K., Schroth, M. K., Graham, R. J., Kirschner, J., Iannaccone, S. T., Crawford, T. O., \u2026 Group, S. M. A. C. (2018). Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care [Practice Guideline Research Support, Non-U.S. Gov\u2019t Review]. Neuromuscular Disorders, 28(2), 103\u2013115. https:\/\/doi.org\/10.1016\/j.nmd.2017.11.005","journal-title":"Neuromuscular Disorders"},{"issue":"10","key":"162_CR198","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/S1474-4422(21)00251-9","volume":"20","author":"E Mercuri","year":"2021","unstructured":"Mercuri, E., Muntoni, F., Baranello, G., Masson, R., Boespflug-Tanguy, O., Bruno, C., Corti, S., Daron, A., Deconinck, N., Servais, L., Straub, V., Ouyang, H., Chand, D., Tauscher-Wisniewski, S., Mendonca, N., Lavrov, A., & group, S. V.-E. s. (2021). Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): An open-label, single-arm, multicentre, phase 3 trial. Lancet Neurology, 20(10), 832\u2013841. https:\/\/doi.org\/10.1016\/S1474-4422(21)00251-9","journal-title":"Lancet Neurology"},{"issue":"12","key":"162_CR199","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.nmd.2017.09.006","volume":"27","author":"S Messina","year":"2017","unstructured":"Messina, S., Pane, M., Sansone, V., Bruno, C., Catteruccia, M., Vita, G., Palermo, C., Albamonte, E., Pedemonte, M., Bertini, E., Binetti, L., Mercuri, E., & Italian, E. A. P. w. G. (2017). Expanded access program with Nusinersen in SMA type I in Italy: Strengths and pitfalls of a successful experience [Editorial]. Neuromuscular Disorders, 27(12), 1084\u20131086. https:\/\/doi.org\/10.1016\/j.nmd.2017.09.006","journal-title":"Neuromuscular Disorders"},{"key":"162_CR200","first-page":"143","volume":"11","author":"DS Middlemas","year":"1991","unstructured":"Middlemas, D. S., Lindberg, R. A., & Hunter, T. (1991). trk B, A neural receptor protein-tyrosine kinase: Evidence for a full-length and two truncated receptors. Molecular and Cellular Biology, 11, 143\u2013153.","journal-title":"Molecular and Cellular Biology"},{"issue":"2","key":"162_CR201","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1056\/NEJMoa2003715","volume":"383","author":"T Miller","year":"2020","unstructured":"Miller, T., Cudkowicz, M., Shaw, P. J., Andersen, P. M., Atassi, N., Bucelli, R. C., Genge, A., Glass, J., Ladha, S., Ludolph, A. L., Maragakis, N. J., McDermott, C. J., Pestronk, A., Ravits, J., Salachas, F., Trudell, R., Van Damme, P., Zinman, L., Bennett, C. F., \u2026 Ferguson, T. A. (2020). Phase 1\u20132 trial of antisense oligonucleotide Tofersen for SOD1 ALS [Clinical Trial, Phase I Clinical Trial, Phase II Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov\u2019t]. New England Journal of Medicine, 383(2), 109\u2013119. https:\/\/doi.org\/10.1056\/NEJMoa2003715","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"162_CR202","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S1474-4422(13)70061-9","volume":"12","author":"TM Miller","year":"2013","unstructured":"Miller, T. M., Pestronk, A., David, W., Rothstein, J., Simpson, E., Appel, S. H., Andres, P. L., Mahoney, K., Allred, P., Alexander, K., Ostrow, L. W., Schoenfeld, D., Macklin, E. A., Norris, D. A., Manousakis, G., Crisp, M., Smith, R., Bennett, C. F., Bishop, K. M., & Cudkowicz, M. E. (2013). An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study [Clinical Trial, Phase I Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov\u2019t. The Lancet Neurology, 12(5), 435\u2013442. https:\/\/doi.org\/10.1016\/S1474-4422(13)70061-9","journal-title":"The Lancet Neurology"},{"key":"162_CR203","first-page":"415","volume-title":"Altered tonic activity of neurons in the globus pallidus and subthalamic nucleus in the primate model of parkjinsonism","author":"WC Miller","year":"1987","unstructured":"Miller, W. C., & DeLong, M. R. (1987). The Basal Ganglia II: Structure and Function. In M. B. Carpenter & A. Jayaraman (Eds.), Altered tonic activity of neurons in the globus pallidus and subthalamic nucleus in the primate model of parkjinsonism (pp. 415\u2013427). Plenum."},{"issue":"6300","key":"162_CR204","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1126\/science.aah5408","volume":"353","author":"S Mizielinska","year":"2016","unstructured":"Mizielinska, S., & Isaacs, A. M. (2016). Neurodegeneration. One target for amyotrophic lateral sclerosis therapy? [Comment]. Science, 353(6300), 647\u2013648. https:\/\/doi.org\/10.1126\/science.aah5408","journal-title":"Science"},{"issue":"6","key":"162_CR205","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s00401-013-1200-z","volume":"126","author":"S Mizielinska","year":"2013","unstructured":"Mizielinska, S., Lashley, T., Norona, F. E., Clayton, E. L., Ridler, C. E., Fratta, P., & Isaacs, A. M. (2013). C9orf72 frontotemporal lobar degeneration is characterised by frequent neuronal sense and antisense RNA foci [Research Support, Non-U.S. Gov\u2019t]. Acta Neuropathologica, 126(6), 845\u2013857. https:\/\/doi.org\/10.1007\/s00401-013-1200-z","journal-title":"Acta Neuropathologica"},{"issue":"7","key":"162_CR206","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1093\/hmg\/8.7.1177","volume":"8","author":"UR Monani","year":"1999","unstructured":"Monani, U. R., Lorson, C. L., Parsons, D. W., Prior, T. W., Androphy, E. J., Burghes, A. H., & McPherson, J. D. (1999). A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Human Molecular Genetics, 8(7), 1177\u20131183.","journal-title":"Human Molecular Genetics"},{"issue":"3","key":"162_CR207","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/S0167-4781(99)00060-3","volume":"1445","author":"UR Monani","year":"1999","unstructured":"Monani, U. R., McPherson, J. D., & Burghes, A. H. (1999). Promoter analysis of the human centromeric and telomeric survival motor neuron genes (SMNC and SMNT) [In Process Citation]. Biochimica et Biophysica Acta, 1445(3), 330\u2013336.","journal-title":"Biochimica et Biophysica Acta"},{"issue":"3","key":"162_CR208","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/hmg\/9.3.333","volume":"9","author":"UR Monani","year":"2000","unstructured":"Monani, U. R., Sendtner, M., Coovert, D. D., Parsons, D. W., Andreassi, C., Le, T. T., Jablonka, S., Schrank, B., Rossoll, W., Prior, T. W., Morris, G. E., & Burghes, A. H. (2000). The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-\/-) mice and results in a mouse with spinal muscular atrophy [Research Support, Non-U.S. Gov\u2019t Research Support, U.S. Gov\u2019t, P.H.S.]. Human Molecular Genetics, 9(3), 333\u2013339. https:\/\/doi.org\/10.1093\/hmg\/9.3.333","journal-title":"Human Molecular Genetics"},{"issue":"4","key":"162_CR209","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/mus.26633","volume":"60","author":"J Montes","year":"2019","unstructured":"Montes, J., Dunaway Young, S., Mazzone, E. S., Pasternak, A., Glanzman, A. M., Finkel, R. S., Darras, B. T., Muntoni, F., Mercuri, E., De Vivo, D. C., Bishop, K. M., Schneider, E., Bennett, C. F., Foster, R., Farwell, W., & Groups, C. S. S. (2019). Nusinersen improves walking distance and reduces fatigue in later-onset spinal muscular atrophy. Muscle and Nerve, 60(4), 409\u2013414. https:\/\/doi.org\/10.1002\/mus.26633","journal-title":"Muscle and Nerve"},{"issue":"6","key":"162_CR210","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0199657","volume":"13","author":"J Montes","year":"2018","unstructured":"Montes, J., McDermott, M. P., Mirek, E., Mazzone, E. S., Main, M., Glanzman, A. M., Duong, T., Young, S. D., Salazar, R., Pasternak, A., Gee, R., De Sanctis, R., Coratti, G., Forcina, N., Fanelli, L., Ramsey, D., Milev, E., Civitello, M., Pane, M., \u2026 Mercuri, E. (2018). Ambulatory function in spinal muscular atrophy: Age-related patterns of progression. PLoS ONE, 13(6), e0199657. https:\/\/doi.org\/10.1371\/journal.pone.0199657","journal-title":"PLoS ONE"},{"issue":"3","key":"162_CR211","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1083\/jcb.201604117","volume":"216","author":"M Moradi","year":"2017","unstructured":"Moradi, M., Sivadasan, R., Saal, L., Luningschror, P., Dombert, B., Rathod, R. J., Dieterich, D. C., Blum, R., & Sendtner, M. (2017). Differential roles of alpha-, beta-, and gamma-actin in axon growth and collateral branch formation in motoneurons. Journal of Cell Biology, 216(3), 793\u2013814. https:\/\/doi.org\/10.1083\/jcb.201604117","journal-title":"Journal of Cell Biology"},{"issue":"6125","key":"162_CR212","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1126\/science.1232927","volume":"339","author":"K Mori","year":"2013","unstructured":"Mori, K., Weng, S. M., Arzberger, T., May, S., Rentzsch, K., Kremmer, E., Schmid, B., Kretzschmar, H. A., Cruts, M., Van Broeckhoven, C., Haass, C., & Edbauer, D. (2013). The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD\/ALS [Research Support, Non-U.S. Gov\u2019t]. Science, 339(6125), 1335\u20131338. https:\/\/doi.org\/10.1126\/science.1232927","journal-title":"Science"},{"issue":"24","key":"162_CR213","doi-asserted-by":"publisher","first-page":"4502","DOI":"10.1038\/emboj.2012.319","volume":"31","author":"M Morlando","year":"2012","unstructured":"Morlando, M., Dini Modigliani, S., Torrelli, G., Rosa, A., Di Carlo, V., Caffarelli, E., & Bozzoni, I. (2012). FUS stimulates microRNA biogenesis by facilitating co-transcriptional Drosha recruitment [Research Support, Non-U.S. Gov\u2019t]. The EMBO Journal, 31(24), 4502\u20134510. https:\/\/doi.org\/10.1038\/emboj.2012.319","journal-title":"The EMBO Journal"},{"issue":"2","key":"162_CR214","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1056\/NEJMoa2005056","volume":"383","author":"C Mueller","year":"2020","unstructured":"Mueller, C., Berry, J. D., McKenna-Yasek, D. M., Gernoux, G., Owegi, M. A., Pothier, L. M., Douthwright, C. L., Gelevski, D., Luppino, S. D., Blackwood, M., Wightman, N. S., Oakley, D. H., Frosch, M. P., Flotte, T. R., Cudkowicz, M. E., & Brown, R. H., Jr. (2020). SOD1 suppression with adeno-associated virus and MicroRNA in familial ALS. New England Journal of Medicine, 383(2), 151\u2013158. https:\/\/doi.org\/10.1056\/NEJMoa2005056","journal-title":"New England Journal of Medicine"},{"key":"162_CR215","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.2119\/molmed.2012.00056","volume":"18","author":"M Murdocca","year":"2012","unstructured":"Murdocca, M., Malgieri, A., Luchetti, A., Saieva, L., Dobrowolny, G., de Leonibus, E., Filareto, A., Quitadamo, M. C., Novelli, G., Musaro, A., & Sangiuolo, F. (2012). IPLEX administration improves motor neuron survival and ameliorates motor functions in a severe mouse model of spinal muscular atrophy. Molecular Medicine, 18, 1076\u20131085.","journal-title":"Molecular Medicine"},{"issue":"3","key":"162_CR216","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nm.1912","volume":"15","author":"AH Nagahara","year":"2009","unstructured":"Nagahara, A. H., Merrill, D. A., Coppola, G., Tsukada, S., Schroeder, B. E., Shaked, G. M., Wang, L., Blesch, A., Kim, A., Conner, J. M., Rockenstein, E., Chao, M. V., Koo, E. H., Geschwind, D., Masliah, E., Chiba, A. A., & Tuszynski, M. H. (2009). Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer\u2019s disease. Nature Medicine, 15(3), 331\u2013337. https:\/\/doi.org\/10.1038\/nm.1912","journal-title":"Nature Medicine"},{"issue":"6197","key":"162_CR217","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1126\/science.1250127","volume":"345","author":"NA Naryshkin","year":"2014","unstructured":"Naryshkin, N. A., Weetall, M., Dakka, A., Narasimhan, J., Zhao, X., Feng, Z., Ling, K. K., Karp, G. M., Qi, H., Woll, M. G., Chen, G., Zhang, N., Gabbeta, V., Vazirani, P., Bhattacharyya, A., Furia, B., Risher, N., Sheedy, J., Kong, R., \u2026 Metzger, F. (2014). Motor neuron disease. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy. Science, 345(6197), 688\u2013693.","journal-title":"Science"},{"issue":"1","key":"162_CR218","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41467-017-02299-1","volume":"9","author":"M Naumann","year":"2018","unstructured":"Naumann, M., Pal, A., Goswami, A., Lojewski, X., Japtok, J., Vehlow, A., Naujock, M., Gunther, R., Jin, M., Stanslowsky, N., Reinhardt, P., Sterneckert, J., Frickenhaus, M., Pan-Montojo, F., Storkebaum, E., Poser, I., Freischmidt, A., Weishaupt, J. H., Holzmann, K., \u2026 Hermann, A. (2018). Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation. Nature Communications, 9(1), 335. https:\/\/doi.org\/10.1038\/s41467-017-02299-1","journal-title":"Nature Communications"},{"issue":"3","key":"162_CR219","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1083\/jcb.200210117","volume":"161","author":"S Nicole","year":"2003","unstructured":"Nicole, S., Desforges, B., Millet, G., Lesbordes, J., Cifuentes-Diaz, C., Vertes, D., Cao, M. L., De Backer, F., Languille, L., Roblot, N., Joshi, V., Gillis, J. M., & Melki, J. (2003). Intact satellite cells lead to remarkable protection against Smn gene defect in differentiated skeletal muscle. Journal of Cell Biology, 161(3), 571\u2013582.","journal-title":"Journal of Cell Biology"},{"issue":"14","key":"162_CR220","doi-asserted-by":"publisher","first-page":"3312","DOI":"10.21769\/BioProtoc.3312","volume":"9","author":"J Nijssen","year":"2019","unstructured":"Nijssen, J., Aguila, J., & Hedlund, E. (2019). Axon-seq for in Depth Analysis of the RNA Content of Neuronal Processes. Bio Protocol, 9(14), 3312. https:\/\/doi.org\/10.21769\/BioProtoc.3312","journal-title":"Bio Protocol"},{"issue":"21","key":"162_CR221","doi-asserted-by":"publisher","first-page":"9906","DOI":"10.1073\/pnas.91.21.9906","volume":"91","author":"CR Nishida","year":"1994","unstructured":"Nishida, C. R., Gralla, E. B., & Valentine, J. S. (1994). Characterization of three yeast copper-zinc superoxide dismutase mutants analogous to those coded for in familial amyotrophic lateral sclerosis. Proceedings of the National Academy of Sciences USA, 91(21), 9906\u20139910. https:\/\/doi.org\/10.1073\/pnas.91.21.9906","journal-title":"Proceedings of the National Academy of Sciences USA"},{"issue":"2","key":"162_CR222","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3390\/brainsci11020194","volume":"11","author":"KS Ojala","year":"2021","unstructured":"Ojala, K. S., Reedich, E. J., DiDonato, C. J., & Meriney, S. D. (2021). In search of a cure: The development of therapeutics to alter the progression of spinal muscular atrophy. Brain Sciences, 11(2), 194. https:\/\/doi.org\/10.3390\/brainsci11020194","journal-title":"Brain Sciences"},{"key":"162_CR223","unstructured":"O\u2019Keefe L. FDA approves oral treatment for spinal muscular atrophy. FDA News Release, August 7, 2020. https:\/\/www.fda.gov\/news-events\/pressannouncements\/fda-approves-oral-treatment-spinal-muscular-atrophy"},{"issue":"5875","key":"162_CR224","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1126\/science.1155085","volume":"320","author":"GE Oprea","year":"2008","unstructured":"Oprea, G. E., Krober, S., McWhorter, M. L., Rossoll, W., Muller, S., Krawczak, M., Bassell, G. J., Beattie, C. E., & Wirth, B. (2008). Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy. Science, 320(5875), 524\u2013527.","journal-title":"Science"},{"issue":"8","key":"162_CR225","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/embor.2012.90","volume":"13","author":"D Orozco","year":"2012","unstructured":"Orozco, D., Tahirovic, S., Rentzsch, K., Schwenk, B. M., Haass, C., & Edbauer, D. (2012). Loss of fused in sarcoma (FUS) promotes pathological Tau splicing. EMBO Reports, 13(8), 759\u2013764. https:\/\/doi.org\/10.1038\/embor.2012.90","journal-title":"EMBO Reports"},{"key":"162_CR226","doi-asserted-by":"publisher","first-page":"6244","DOI":"10.1038\/ncomms7244","volume":"6","author":"DG Ousterout","year":"2015","unstructured":"Ousterout, D. G., Kabadi, A. M., Thakore, P. I., Majoros, W. H., Reddy, T. E., & Gersbach, C. A. (2015). Multiplex CRISPR\/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov\u2019t Research Support, U.S. Gov\u2019t, Non-P.H.S.]. Nature Communications, 6, 6244. https:\/\/doi.org\/10.1038\/ncomms7244","journal-title":"Nature Communications"},{"issue":"7","key":"162_CR227","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nchembio.1837","volume":"11","author":"J Palacino","year":"2015","unstructured":"Palacino, J., Swalley, S. E., Song, C., Cheung, A. K., Shu, L., Zhang, X., Van, H. M., Shin, Y., Chin, D. N., Keller, C. G., Beibel, M., Renaud, N. A., Smith, T. M., Salcius, M., Shi, X., Hild, M., Servais, R., Jain, M., Deng, L., \u2026 Sivasankaran, R. (2015). SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice. Nature Chemical Biology, 11(7), 511\u2013517.","journal-title":"Nature Chemical Biology"},{"issue":"2","key":"162_CR228","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41582-018-0116-6","volume":"15","author":"F Panza","year":"2019","unstructured":"Panza, F., Lozupone, M., Logroscino, G., & Imbimbo, B. P. (2019). A critical appraisal of amyloid-beta-targeting therapies for Alzheimer disease [Review]. Nature Reviews. Neurology, 15(2), 73\u201388. https:\/\/doi.org\/10.1038\/s41582-018-0116-6","journal-title":"Nature Reviews. Neurology"},{"issue":"6","key":"162_CR229","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1136\/jmg.15.6.409","volume":"15","author":"J Pearn","year":"1978","unstructured":"Pearn, J. (1978). Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy. Journal of Medical Genetics, 15(6), 409\u2013413.","journal-title":"Journal of Medical Genetics"},{"issue":"8174","key":"162_CR230","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S0140-6736(80)90847-8","volume":"1","author":"J Pearn","year":"1980","unstructured":"Pearn, J. (1980). Classification of spinal muscular atrophies. Lancet, 1(8174), 919\u2013922.","journal-title":"Lancet"},{"issue":"3","key":"162_CR231","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1136\/jmg.10.3.260","volume":"10","author":"JH Pearn","year":"1973","unstructured":"Pearn, J. H. (1973). The gene frequency of acute Werdnig-Hoffmann disease (SMA type 1). A total population survey in North-East England. Journal of Medical Genetics, 10(3), 260\u2013265.","journal-title":"Journal of Medical Genetics"},{"issue":"2","key":"162_CR232","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3233\/JND-180315","volume":"5","author":"A Pechmann","year":"2018","unstructured":"Pechmann, A., Langer, T., Schorling, D., Stein, S., Vogt, S., Schara, U., Kolbel, H., Schwartz, O., Hahn, A., Giese, K., Johannsen, J., Denecke, J., Weiss, C., Theophil, M., & Kirschner, J. (2018). Evaluation of children with SMA Type 1 under treatment with Nusinersen within the expanded access program in Germany. Journal of Neuromuscular Diseases, 5(2), 135\u2013143. https:\/\/doi.org\/10.3233\/JND-180315","journal-title":"Journal of Neuromuscular Diseases"},{"key":"162_CR233","doi-asserted-by":"crossref","unstructured":"Pellizzoni, L., Kataoka, N., Charroux, B., & Dreyfuss, G. (1998). A novel function for SMN, the spinal muscular atrophy disease gene product, in pre-mRNA splicing. Cell 77(5), 727\u2013736, 95(5), 615\u2013624.","DOI":"10.1016\/S0092-8674(00)81632-3"},{"issue":"1","key":"162_CR234","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0896-6273(00)80281-0","volume":"17","author":"D Pennica","year":"1996","unstructured":"Pennica, D., Arce, V., Swanson, T. A., Vejsada, R., Pollock, R. A., Armanini, M., Dudley, K., Phillips, H. S., Rosenthal, A., Kato, A. C., & Henderson, C. E. (1996). Cardiotrophin-1, a cytokine present in embryonic muscle, supports long-term survival of spinal motoneurons. Neuron, 17(1), 63\u201374.","journal-title":"Neuron"},{"key":"162_CR235","doi-asserted-by":"publisher","first-page":"10915","DOI":"10.1074\/jbc.270.18.10915","volume":"270","author":"D Pennica","year":"1995","unstructured":"Pennica, D., Shaw, K. J., Swanson, T. A., Moore, M. W., Shelton, D. L., Zioncheck, K. A., Rosenthal, A., Taga, T., Paoni, N. F., & Wood, W. I. (1995). Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor\/gp130 signaling complex. Journal of Biological Chemistry, 270, 10915\u201310922.","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"162_CR236","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1038\/s41598-018-20524-9","volume":"8","author":"M Pirruccello-Straub","year":"2018","unstructured":"Pirruccello-Straub, M., Jackson, J., Wawersik, S., Webster, M. T., Salta, L., Long, K., McConaughy, W., Capili, A., Boston, C., Carven, G. J., Mahanthappa, N. K., Turner, K. J., & Donovan, A. (2018). Blocking extracellular activation of myostatin as a strategy for treating muscle wasting. Science and Reports, 8(1), 2292. https:\/\/doi.org\/10.1038\/s41598-018-20524-9","journal-title":"Science and Reports"},{"issue":"6","key":"162_CR237","doi-asserted-by":"publisher","first-page":"e00447","DOI":"10.1002\/prp2.447","volume":"6","author":"A Poirier","year":"2018","unstructured":"Poirier, A., Weetall, M., Heinig, K., Bucheli, F., Schoenlein, K., Alsenz, J., Bassett, S., Ullah, M., Senn, C., Ratni, H., Naryshkin, N., Paushkin, S., & Mueller, L. (2018). Risdiplam distributes and increases SMN protein in both the central nervous system and peripheral organs [Research Support, Non-U.S. Gov\u2019t]. Pharmacology Research & Perspectives, 6(6), e00447. https:\/\/doi.org\/10.1002\/prp2.447","journal-title":"Pharmacology Research & Perspectives"},{"issue":"3","key":"162_CR238","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/ng1196-269","volume":"14","author":"SM Pulst","year":"1996","unstructured":"Pulst, S. M., Nechiporuk, A., Nechiporuk, T., Gispert, S., Chen, X. N., Lopes-Cendes, I., Pearlman, S., Starkman, S., Orozco-Diaz, G., Lunkes, A., DeJong, P., Rouleau, G. A., Auburger, G., Korenberg, J. R., Figueroa, C., & Sahba, S. (1996). Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nature Genetics, 14(3), 269\u2013276. https:\/\/doi.org\/10.1038\/ng1196-269","journal-title":"Nature Genetics"},{"issue":"3","key":"162_CR239","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1080\/14656566.2019.1704732","volume":"21","author":"S Ramdas","year":"2020","unstructured":"Ramdas, S., & Servais, L. (2020). New treatments in spinal muscular atrophy: An overview of currently available data [Review]. Expert Opinion on Pharmacotherapy, 21(3), 307\u2013315. https:\/\/doi.org\/10.1080\/14656566.2019.1704732","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"11","key":"162_CR240","doi-asserted-by":"publisher","first-page":"4817","DOI":"10.1172\/JCI124120","volume":"129","author":"DM Ramos","year":"2019","unstructured":"Ramos, D. M., d\u2019Ydewalle, C., Gabbeta, V., Dakka, A., Klein, S. K., Norris, D. A., Matson, J., Taylor, S. J., Zaworski, P. G., Prior, T. W., Snyder, P. J., Valdivia, D., Hatem, C. L., Waters, I., Gupte, N., Swoboda, K. J., Rigo, F., Bennett, C. F., Naryshkin, N., \u2026 Sumner, C. J. (2019). Age-dependent SMN expression in disease-relevant tissue and implications for SMA treatment [Clinical Trial Research Support, N.I.H., xtramural Research Support, Non-U.S. Gov\u2019t]. Journal of Clinical Investigation, 129(11), 4817\u20134831. https:\/\/doi.org\/10.1172\/JCI124120","journal-title":"Journal of Clinical Investigation"},{"issue":"3","key":"162_CR241","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.ymthe.2019.01.002","volume":"27","author":"JN Ramos","year":"2019","unstructured":"Ramos, J. N., Hollinger, K., Bengtsson, N. E., Allen, J. M., Hauschka, S. D., & Chamberlain, J. S. (2019). Development of novel micro-dystrophins with enhanced functionality [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov\u2019t]. Molecular Therapy, 27(3), 623\u2013635. https:\/\/doi.org\/10.1016\/j.ymthe.2019.01.002","journal-title":"Molecular Therapy"},{"issue":"15","key":"162_CR242","doi-asserted-by":"publisher","first-page":"6501","DOI":"10.1021\/acs.jmedchem.8b00741","volume":"61","author":"H Ratni","year":"2018","unstructured":"Ratni, H., Ebeling, M., Baird, J., Bendels, S., Bylund, J., Chen, K. S., Denk, N., Feng, Z., Green, L., Guerard, M., Jablonski, P., Jacobsen, B., Khwaja, O., Kletzl, H., Ko, C. P., Kustermann, S., Marquet, A., Metzger, F., Mueller, B., \u2026 Mueller, L. (2018). Discovery of Risdiplam, a selective Survival of Motor Neuron-2 (SMN2) gene splicing modifier for the treatment of spinal muscular atrophy (SMA). Journal of Medicinal Chemistry, 61(15), 6501\u20136517. https:\/\/doi.org\/10.1021\/acs.jmedchem.8b00741","journal-title":"Journal of Medicinal Chemistry"},{"issue":"13","key":"162_CR243","doi-asserted-by":"publisher","first-page":"6086","DOI":"10.1021\/acs.jmedchem.6b00459","volume":"59","author":"H Ratni","year":"2016","unstructured":"Ratni, H., Karp, G. M., Weetall, M., Naryshkin, N. A., Paushkin, S. V., Chen, K. S., McCarthy, K. D., Qi, H., Turpoff, A., Woll, M. G., Zhang, X., Zhang, N., Yang, T., Dakka, A., Vazirani, P., Zhao, X., Pinard, E., Green, L., David-Pierson, P., \u2026 Metzger, F. (2016). Specific correction of alternative survival motor Neuron 2 splicing by small molecules: Discovery of a potential novel medicine to treat spinal muscular atrophy [Research Support, Non-US Gov\u2019t]. Journal of Medicinal Chemistry, 59(13), 6086\u20136100. https:\/\/doi.org\/10.1021\/acs.jmedchem.6b00459","journal-title":"Journal of Medicinal Chemistry"},{"issue":"1","key":"162_CR244","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/ng0596-43","volume":"13","author":"AG Reaume","year":"1996","unstructured":"Reaume, A. G., Elliott, J. L., Hoffman, E. K., Kowall, N. W., Ferrante, R. J., Siwek, D. F., Wilcox, H. M., Flood, D. G., Beal, M. F., Brown, R. H., Jr., Scott, R. W., & Snider, W. D. (1996). Motor neurons in Cu\/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nature Genetics, 13(1), 43\u201347.","journal-title":"Nature Genetics"},{"key":"162_CR245","doi-asserted-by":"publisher","unstructured":"Renton, A. E., Majounie, E., Waite, A., Simon-Sanchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., Kalimo, H., Paetau, A., Abramzon, Y., Remes, A. M., Kaganovich, A., Scholz, S. W., Duckworth, J., Ding, J., Harmer, D. W., Hernandez, D. G., Johnson, J. O., Mok, K., Ryten, M., Trabzuni, D., Guerreiro, R. J., Orrell, R. W., Neal, J., Murray, A., Pearson, J., Jansen, I. E., Sondervan, D., Seelaar, H., Blake, D., Young, K., Halliwell, N., Callister, J. B., Toulson, G., Richardson, A., Gerhard, A., Snowden, J., Mann, D., Neary, D., Nalls, M. A., Peuralinna, T., Jansson, L., Isoviita, V. M., Kaivorinne, A. L., Holtta-Vuori, M., Ikonen, E., Sulkava, R., Benatar, M., Wuu, J., Chio, A., Restagno, G., Borghero, G., Sabatelli, M., Consortium, I., Heckerman, D., Rogaeva, E., Zinman, L., Rothstein, J. D., Sendtner, M., Drepper, C., Eichler, E. E., Alkan, C., Abdullaev, Z., Pack, S. D., Dutra, A., Pak, E., Hardy, J., Singleton, A., Williams, N. M., Heutink, P., Pickering-Brown, S., Morris, H. R., Tienari, P. J., & Traynor, B. J. (2011). A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD [Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.]. Neuron, 72(2), 257\u2013268. https:\/\/doi.org\/10.1016\/j.neuron.2011.09.010","DOI":"10.1016\/j.neuron.2011.09.010"},{"issue":"2","key":"162_CR246","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ajhg.2017.01.005","volume":"100","author":"M Riessland","year":"2017","unstructured":"Riessland, M., Kaczmarek, A., Schneider, S., Swoboda, K. J., Lohr, H., Bradler, C., Grysko, V., Dimitriadi, M., Hosseinibarkooie, S., Torres-Benito, L., Peters, M., Upadhyay, A., Biglari, N., Krober, S., Holker, I., Garbes, L., Gilissen, C., Hoischen, A., Nurnberg, G., \u2026 Wirth, B. (2017). Neurocalcin delta suppression protects against spinal muscular atrophy in humans and across species by restoring impaired endocytosis. American Journal of Human Genetics, 100(2), 297\u2013315. https:\/\/doi.org\/10.1016\/j.ajhg.2017.01.005","journal-title":"American Journal of Human Genetics"},{"issue":"1","key":"162_CR247","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1083\/jcb.201207087","volume":"199","author":"F Rigo","year":"2012","unstructured":"Rigo, F., Hua, Y., Krainer, A. R., & Bennett, C. F. (2012). Antisense-based therapy for the treatment of spinal muscular atrophy [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov\u2019t]. The Journal of Cell Biology, 199(1), 21\u201325. https:\/\/doi.org\/10.1083\/jcb.201207087","journal-title":"The Journal of Cell Biology"},{"issue":"3","key":"162_CR248","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.nmd.2011.10.012","volume":"22","author":"H Rindt","year":"2012","unstructured":"Rindt, H., Buckley, D. M., Vale, S. M., Krogman, M., Rose, F. F., Jr., Garcia, M. L., & Lorson, C. L. (2012). Transgenic inactivation of murine myostatin does not decrease the severity of disease in a model of Spinal Muscular Atrophy. Neuromuscular Disorders, 22(3), 277\u2013285. https:\/\/doi.org\/10.1016\/j.nmd.2011.10.012","journal-title":"Neuromuscular Disorders"},{"issue":"17","key":"162_CR249","doi-asserted-by":"publisher","first-page":"4559","DOI":"10.1093\/hmg\/ddu169","volume":"23","author":"KL Robbins","year":"2014","unstructured":"Robbins, K. L., Glascock, J. J., Osman, E. Y., Miller, M. R., & Lorson, C. L. (2014). Defining the therapeutic window in a severe animal model of spinal muscular atrophy [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov\u2019t]. Human Molecular Genetics, 23(17), 4559\u20134568. https:\/\/doi.org\/10.1093\/hmg\/ddu169","journal-title":"Human Molecular Genetics"},{"issue":"10","key":"162_CR250","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","volume":"19","author":"TC Roberts","year":"2020","unstructured":"Roberts, T. C., Langer, R., & Wood, M. J. A. (2020). Advances in oligonucleotide drug delivery. Nature Reviews Drug Discovery, 19(10), 673\u2013694. https:\/\/doi.org\/10.1038\/s41573-020-0075-7","journal-title":"Nature Reviews Drug Discovery"},{"issue":"3","key":"162_CR251","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s004390100473","volume":"108","author":"CF Rochette","year":"2001","unstructured":"Rochette, C. F., Gilbert, N., & Simard, L. R. (2001). SMN gene duplication and the emergence of the SMN2 gene occurred in distinct hominids: SMN2 is unique to Homo sapiens [Comparative Study Research Support, Non-U.S. Gov\u2019t]. Human Genetics, 108(3), 255\u2013266. https:\/\/doi.org\/10.1007\/s004390100473","journal-title":"Human Genetics"},{"key":"162_CR252","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/srep00603","volume":"2","author":"B Rogelj","year":"2012","unstructured":"Rogelj, B., Easton, L. E., Bogu, G. K., Stanton, L. W., Rot, G., Curk, T., Zupan, B., Sugimoto, Y., Modic, M., Haberman, N., Tollervey, J., Fujii, R., Takumi, T., Shaw, C. E., & Ule, J. (2012). Widespread binding of FUS along nascent RNA regulates alternative splicing in the brain [Research Support, Non-U.S. Gov\u2019t]. Scientific Reports, 2, 603. https:\/\/doi.org\/10.1038\/srep00603","journal-title":"Scientific Reports"},{"issue":"3","key":"162_CR253","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S1474-4422(14)70233-9","volume":"14","author":"JD Rohrer","year":"2015","unstructured":"Rohrer, J. D., Isaacs, A. M., Mizielinska, S., Mead, S., Lashley, T., Wray, S., Sidle, K., Fratta, P., Orrell, R. W., Hardy, J., Holton, J., Revesz, T., Rossor, M. N., & Warren, J. D. (2015). C9orf72 expansions in frontotemporal dementia and amyotrophic lateral sclerosis [Case Reports Research Support, Non-U.S. Gov\u2019t Review]. The Lancet Neurology, 14(3), 291\u2013301. https:\/\/doi.org\/10.1016\/S1474-4422(14)70233-9","journal-title":"The Lancet Neurology"},{"key":"162_CR254","doi-asserted-by":"crossref","unstructured":"Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H. X., Rahmani, Z., Krizus, A., McKenna-Yasek, D., Cayabyab, A., Gaston, S. M., Berger, R., Tanzi, R. E., Halperin, J. J., Herzfeldt, B., Van den Berg, R., Hung, W. Y., Bird, T., Deng, G., Mulder, D. W., Smyth, C., Laing, N. G., Soriano, E., Pericak-Vance, M. A., Haines, J., Rouleau, G. A., Gusella, J. S., Horvitz, H. R., & Brown Jr, R. H. (1993). Mutation in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 377(6547): 340\u2013344, 362, 59\u201362.","DOI":"10.1038\/362059a0"},{"issue":"4","key":"162_CR255","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1083\/jcb.200304128","volume":"163","author":"W Rossoll","year":"2003","unstructured":"Rossoll, W., Jablonka, S., Andreassi, C., Kroning, A. K., Karle, K., Monani, U. R., & Sendtner, M. (2003). Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of beta-actin mRNA in growth cones of motoneurons. Journal of Cell Biology, 163(4), 801\u2013812.","journal-title":"Journal of Cell Biology"},{"issue":"1","key":"162_CR256","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/hmg\/11.1.93","volume":"11","author":"W Rossoll","year":"2002","unstructured":"Rossoll, W., Kroning, A. K., Ohndorf, U. M., Steegborn, C., Jablonka, S., & Sendtner, M. (2002). Specific interaction of Smn, the spinal muscular atrophy determining gene product, with hnRNP-R and gry-rbp\/hnRNP-Q: A role for Smn in RNA processing in motor axons? Human Molecular Genetics, 11(1), 93\u2013105.","journal-title":"Human Molecular Genetics"},{"issue":"Pt 2","key":"162_CR257","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1042\/BJ20041024","volume":"385","author":"R Rouget","year":"2005","unstructured":"Rouget, R., Vigneault, F., Codio, C., Rochette, C., Paradis, I., Drouin, R., & Simard, L. R. (2005). Characterization of the survival motor neuron (SMN) promoter provides evidence for complex combinatorial regulation in undifferentiated and differentiated P19 cells [Research Support, Non-U.S. Gov\u2019t]. Biochemical Journal, 385(Pt 2), 433\u2013443. https:\/\/doi.org\/10.1042\/BJ20041024","journal-title":"Biochemical Journal"},{"key":"162_CR258","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-020-01004-3","author":"SA Rudnicki","year":"2021","unstructured":"Rudnicki, S. A., Andrews, J. A., Duong, T., Cockroft, B. M., Malik, F. I., Meng, L., Wei, J., Wolff, A. A., Genge, A., Johnson, N. E., Tesi-Rocha, C., Connolly, A. M., Darras, B. T., Felice, K., Shieh, P. B., Mah, J. K., Statland, J., Campbell, C., Habib, A. A., \u2026 Day, J. W. (2021). Reldesemtiv in patients with spinal muscular atrophy: A phase 2 hypothesis-generating study. Neurotherapeutics. https:\/\/doi.org\/10.1007\/s13311-020-01004-3","journal-title":"Neurotherapeutics"},{"issue":"3","key":"162_CR259","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1055\/s-2004-820994","volume":"35","author":"S Rudnik-Schoneborn","year":"2004","unstructured":"Rudnik-Schoneborn, S., Stolz, P., Varon, R., Grohmann, K., Schachtele, M., Ketelsen, U. P., Stavrou, D., Kurz, H., Hubner, C., & Zerres, K. (2004). Long-term observations of patients with infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1). Neuropediatrics, 35(3), 174\u2013182.","journal-title":"Neuropediatrics"},{"issue":"3","key":"162_CR260","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1523\/JNEUROSCI.4496-09.2010","volume":"30","author":"R Ruiz","year":"2010","unstructured":"Ruiz, R., Casanas, J. J., Torres-Benito, L., Cano, R., & Tabares, L. (2010). Altered intracellular Ca2+ homeostasis in nerve terminals of severe spinal muscular atrophy mice. Journal of Neuroscience, 30(3), 849\u2013857.","journal-title":"Journal of Neuroscience"},{"issue":"11","key":"162_CR261","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1261\/rna.047373.114","volume":"20","author":"L Saal","year":"2014","unstructured":"Saal, L., Briese, M., Kneitz, S., Glinka, M., & Sendtner, M. (2014). Subcellular transcriptome alterations in a cell culture model of spinal muscular atrophy point to widespread defects in axonal growth and presynaptic differentiation. RNA, 20(11), 1789\u20131802.","journal-title":"RNA"},{"issue":"3","key":"162_CR262","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/ng1196-277","volume":"14","author":"K Sanpei","year":"1996","unstructured":"Sanpei, K., Takano, H., Igarashi, S., Sato, T., Oyake, M., Sasaki, H., Wakisaka, A., Tashiro, K., Ishida, Y., Ikeuchi, T., Koide, R., Saito, M., Sato, A., Tanaka, T., Hanyu, S., Takiyama, Y., Nishizawa, M., Shimizu, N., Nomura, Y., \u2026 Tsuji, S. (1996). Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nature Genetics, 14(3), 277\u2013284. https:\/\/doi.org\/10.1038\/ng1196-277","journal-title":"Nature Genetics"},{"issue":"3","key":"162_CR263","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1006\/geno.1996.0644","volume":"38","author":"JM Scharf","year":"1996","unstructured":"Scharf, J. M., Damron, D., Frisella, A., Bruno, S., Beggs, A. H., Kunkel, L. M., & Dietrich, W. F. (1996). The mouse region syntenic for human spinal muscular atrophy lies within the Lgn1 critical interval and contains multiple copies of Naip exon 5. Genomics, 38(3), 405\u2013417.","journal-title":"Genomics"},{"issue":"18","key":"162_CR264","doi-asserted-by":"publisher","first-page":"9920","DOI":"10.1073\/pnas.94.18.9920","volume":"94","author":"B Schrank","year":"1997","unstructured":"Schrank, B., Gotz, R., Gunnersen, J. M., Ure, J. M., Toyka, K. V., Smith, A. G., & Sendtner, M. (1997). Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos. Proceedings of the National academy of Sciences of the United States of America, 94(18), 9920\u20139925.","journal-title":"Proceedings of the National academy of Sciences of the United States of America"},{"key":"162_CR265","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1242\/jcs.1991.Supplement_15.14","volume":"15","author":"M Sendtner","year":"1991","unstructured":"Sendtner, M., Arakawa, Y., St\u201dckli, K. A., Kreutzberg, G. W., & Thoenen, H. (1991). Effect of ciliary neurotrophic factor (CNTF) on motoneuron survival. Journal of Cell Science Supplement, 15, 103\u2013109.","journal-title":"Journal of Cell Science Supplement"},{"key":"162_CR266","doi-asserted-by":"crossref","unstructured":"Sendtner, M., Holtmann, B., Kolbeck, R., Thoenen, H., & Barde, Y. A. (1992). Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section. Nature 377(6547), 340\u2013344, 360, 757\u2013758","DOI":"10.1038\/360757a0"},{"key":"162_CR267","doi-asserted-by":"crossref","unstructured":"Sendtner, M., Kreutzberg, G. W., & Thoenen, H. (1990). Ciliary neurotrophic factor prevents the degeneration of motor neurons after axotomy. Nature 377(6547), 340\u20134, 345, 440\u2013441.","DOI":"10.1038\/345440a0"},{"key":"162_CR268","doi-asserted-by":"crossref","unstructured":"Sendtner, M., Schmalbruch, H., Stockli, K. A., Carroll, P., Kreutzberg, G. W., & Thoenen, H. (1992). Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant progressive motor neuronopathy. Nature 377(6547): 340\u2013344, 358(6386), 502\u2013504.","DOI":"10.1038\/358502a0"},{"key":"162_CR269","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/S0960-9822(00)00237-2","volume":"4","author":"M Sendtner","year":"1994","unstructured":"Sendtner, M., & Thoenen, H. (1994). Neurodegenerative disease: Oxidative stress and motorneuron disease. Current Biology, 4, 1036\u20131039.","journal-title":"Current Biology"},{"issue":"1","key":"162_CR270","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/acn3.51239","volume":"8","author":"RC Sergott","year":"2021","unstructured":"Sergott, R. C., Amorelli, G. M., Baranello, G., Barreau, E., Beres, S., Kane, S., Mercuri, E., Orazi, L., SantaMaria, M., Tremolada, G., Santarsiero, D., Waskowska, A., Yashiro, S., Denk, N., Furst-Recktenwald, S., Gerber, M., Gorni, K., Jaber, B., Jacobsen, B., \u2026 Firefish, S. J. W. G. (2021). Risdiplam treatment has not led to retinal toxicity in patients with spinal muscular atrophy [Research Support, Non-U.S. Gov\u2019t]. Annals of Clinical and Translational Neurology, 8(1), 54\u201365. https:\/\/doi.org\/10.1002\/acn3.51239","journal-title":"Annals of Clinical and Translational Neurology"},{"issue":"1","key":"162_CR271","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.yexcr.2005.08.019","volume":"311","author":"D Shafey","year":"2005","unstructured":"Shafey, D., Cote, P. D., & Kothary, R. (2005). Hypomorphic Smn knockdown C2C12 myoblasts reveal intrinsic defects in myoblast fusion and myotube morphology. Experimental Cell Research, 311(1), 49\u201361. https:\/\/doi.org\/10.1016\/j.yexcr.2005.08.019","journal-title":"Experimental Cell Research"},{"issue":"5","key":"162_CR272","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1093\/jnen\/59.5.398","volume":"59","author":"G Simic","year":"2000","unstructured":"Simic, G., Seso-Simic, D., Lucassen, P. J., Islam, A., Krsnik, Z., Cviko, A., Jelasic, D., Barisic, N., Winblad, B., Kostovic, I., & Kruslin, B. (2000). Ultrastructural analysis and TUNEL demonstrate motor neuron apoptosis in Werdnig-Hoffmann disease [Research Support, Non-U.S. Gov\u2019t]. Journal of Neuropathology and Experimental Neurology, 59(5), 398\u2013407. https:\/\/doi.org\/10.1093\/jnen\/59.5.398","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"issue":"2","key":"162_CR273","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1523\/JNEUROSCI.2142-20.2020","volume":"41","author":"CM Simon","year":"2021","unstructured":"Simon, C. M., Blanco-Redondo, B., Buettner, J. M., Pagiazitis, J. G., Fletcher, E. V., Sime Longang, J. K., & Mentis, G. Z. (2021). Chronic pharmacological increase of neuronal activity improves sensory-motor dysfunction in spinal muscular atrophy mice. Journal of Neuroscience, 41(2), 376\u2013389. https:\/\/doi.org\/10.1523\/JNEUROSCI.2142-20.2020","journal-title":"Journal of Neuroscience"},{"issue":"6","key":"162_CR274","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1093\/hmg\/ddp562","volume":"19","author":"CM Simon","year":"2010","unstructured":"Simon, C. M., Jablonka, S., Ruiz, R., Tabares, L., & Sendtner, M. (2010). Ciliary neurotrophic factor-induced sprouting preserves motor function in a mouse model of mild spinal muscular atrophy [Research Support, Non-U.S. Gov\u2019t]. Human Molecular Genetics, 19(6), 973\u2013986. https:\/\/doi.org\/10.1093\/hmg\/ddp562","journal-title":"Human Molecular Genetics"},{"issue":"12","key":"162_CR275","doi-asserted-by":"publisher","first-page":"3885","DOI":"10.1016\/j.celrep.2019.11.058","volume":"29","author":"CM Simon","year":"2019","unstructured":"Simon, C. M., Van Alstyne, M., Lotti, F., Bianchetti, E., Tisdale, S., Watterson, D. M., Mentis, G. Z., & Pellizzoni, L. (2019). Stasimon Contributes to the Loss of Sensory Synapses and Motor Neuron Death in a Mouse Model of Spinal Muscular Atrophy. Cell Report, 29(12), 3885-3901e3885. https:\/\/doi.org\/10.1016\/j.celrep.2019.11.058","journal-title":"Cell Report"},{"key":"162_CR276","doi-asserted-by":"publisher","first-page":"263310552097398","DOI":"10.1177\/2633105520973985","volume":"15","author":"RN Singh","year":"2020","unstructured":"Singh, R. N., Ottesen, E. W., & Singh, N. N. (2020). The first orally deliverable small molecule for the treatment of spinal muscular atrophy [review]. Neuroscience Insights, 15, 2633105520973985. https:\/\/doi.org\/10.1177\/2633105520973985","journal-title":"Neuroscience Insights"},{"key":"162_CR277","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/978-3-319-89689-2_2","volume":"20","author":"RN Singh","year":"2018","unstructured":"Singh, R. N., & Singh, N. N. (2018). Mechanism of splicing regulation of spinal muscular atrophy genes. Advances in Neurobiology, 20, 31\u201361. https:\/\/doi.org\/10.1007\/978-3-319-89689-2_2","journal-title":"Advances in Neurobiology"},{"issue":"12","key":"162_CR278","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1038\/nn.4407","volume":"19","author":"R Sivadasan","year":"2016","unstructured":"Sivadasan, R., Hornburg, D., Drepper, C., Frank, N., Jablonka, S., Hansel, A., Lojewski, X., Sterneckert, J., Hermann, A., Shaw, P. J., Ince, P. G., Mann, M., Meissner, F., & Sendtner, M. (2016). C9ORF72 interaction with cofilin modulates actin dynamics in motor neurons. Nature Neuroscience, 19(12), 1610\u20131618. https:\/\/doi.org\/10.1038\/nn.4407","journal-title":"Nature Neuroscience"},{"key":"162_CR279","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/978-1-4939-8651-4_3","volume":"1828","author":"HW Son","year":"2018","unstructured":"Son, H. W., & Yokota, T. (2018). Recent advances and clinical applications of exon inclusion for spinal muscular atrophy [Research Support, Non-U.S. Gov\u2019t Review]. Methods in Molecular Biology, 1828, 57\u201368. https:\/\/doi.org\/10.1007\/978-1-4939-8651-4_3","journal-title":"Methods in Molecular Biology"},{"issue":"10","key":"162_CR280","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1038\/s41591-019-0594-0","volume":"25","author":"Y Song","year":"2019","unstructured":"Song, Y., Morales, L., Malik, A. S., Mead, A. F., Greer, C. D., Mitchell, M. A., Petrov, M. T., Su, L. T., Choi, M. E., Rosenblum, S. T., Lu, X., VanBelzen, D. J., Krishnankutty, R. K., Balzer, F. J., Loro, E., French, R., Propert, K. J., Zhou, S., Kozyak, B. W., \u2026 Stedman, H. H. (2019). Non-immunogenic utrophin gene therapy for the treatment of muscular dystrophy animal models [Research Support, NIH, Extramural Research Support, Non-U.S. Gov\u2019t]. Nature Medicine, 25(10), 1505\u20131511. https:\/\/doi.org\/10.1038\/s41591-019-0594-0","journal-title":"Nature Medicine"},{"key":"162_CR281","doi-asserted-by":"crossref","unstructured":"Soppet, D., Escandon, E., Maragos, J., Middlemas, D. S., Reid, S. W., Blair, J., Burton, L. E., Stanton, B. R., Kaplan, D. R., Hunter, T., Nikolics, K., & Parada, L. F. (1991). The neurotrophic factors brain-derived neurotrophic factor and neurotrophin-3 are ligands for the trk B tyrosine kinase receptor. Cell 77(5): 727\u2013736, 65, 895\u2013903.","DOI":"10.1016\/0092-8674(91)90396-G"},{"issue":"10","key":"162_CR282","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1001\/archneurol.2010.239","volume":"67","author":"G Stratigopoulos","year":"2010","unstructured":"Stratigopoulos, G., Lanzano, P., Deng, L., Guo, J., Kaufmann, P., Darras, B., Finkel, R., Tawil, R., McDermott, M. P., Martens, W., Devivo, D. C., & Chung, W. K. (2010). Association of plastin 3 expression with disease severity in spinal muscular atrophy only in postpubertal females [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov\u2019t]. Archives of Neurology, 67(10), 1252\u20131256. https:\/\/doi.org\/10.1001\/archneurol.2010.239","journal-title":"Archives of Neurology"},{"issue":"10","key":"162_CR283","doi-asserted-by":"publisher","first-page":"e610","DOI":"10.1097\/BPO.0000000000001247","volume":"38","author":"KA Strauss","year":"2018","unstructured":"Strauss, K. A., Carson, V. J., Brigatti, K. W., Young, M., Robinson, D. L., Hendrickson, C., Fox, M. D., Reed, R. M., Puffenberger, E. G., Mackenzie, W., & Miller, F. (2018). Preliminary Safety and Tolerability of a Novel Subcutaneous Intrathecal Catheter System for Repeated Outpatient Dosing of Nusinersen to Children and Adults With Spinal Muscular Atrophy. Journal of Pediatric Orthopedics, 38(10), e610\u2013e617. https:\/\/doi.org\/10.1097\/BPO.0000000000001247","journal-title":"Journal of Pediatric Orthopedics"},{"issue":"17","key":"162_CR284","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.1093\/hmg\/ddp253","volume":"18","author":"CJ Sumner","year":"2009","unstructured":"Sumner, C. J., Wee, C. D., Warsing, L. C., Choe, D. W., Ng, A. S., Lutz, C., & Wagner, K. R. (2009). Inhibition of myostatin does not ameliorate disease features of severe spinal muscular atrophy mice. Human Molecular Genetics, 18(17), 3145\u20133152. https:\/\/doi.org\/10.1093\/hmg\/ddp253","journal-title":"Human Molecular Genetics"},{"issue":"7","key":"162_CR285","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1016\/j.neuropharm.2012.02.013","volume":"62","author":"C Sunyach","year":"2012","unstructured":"Sunyach, C., Michaud, M., Arnoux, T., Bernard-Marissal, N., Aebischer, J., Latyszenok, V., Gouarne, C., Raoul, C., Pruss, R. M., Bordet, T., & Pettmann, B. (2012). Olesoxime delays muscle denervation, astrogliosis, microglial activation and motoneuron death in an ALS mouse model [Comparative Study Research Support, Non-U.S. Gov\u2019t]. Neuropharmacology, 62(7), 2346\u20132352. https:\/\/doi.org\/10.1016\/j.neuropharm.2012.02.013","journal-title":"Neuropharmacology"},{"issue":"3","key":"162_CR286","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00401-017-1796-5","volume":"135","author":"B Swinnen","year":"2018","unstructured":"Swinnen, B., Bento-Abreu, A., Gendron, T. F., Boeynaems, S., Bogaert, E., Nuyts, R., Timmers, M., Scheveneels, W., Hersmus, N., Wang, J., Mizielinska, S., Isaacs, A. M., Petrucelli, L., Lemmens, R., Van Damme, P., Van Den Bosch, L., & Robberecht, W. (2018). A zebrafish model for C9orf72 ALS reveals RNA toxicity as a pathogenic mechanism [Research Support, Non-U.S. Gov\u2019t]. Acta Neuropathologica, 135(3), 427\u2013443. https:\/\/doi.org\/10.1007\/s00401-017-1796-5","journal-title":"Acta Neuropathologica"},{"issue":"10","key":"162_CR287","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1212\/WNL.0000000000008074","volume":"93","author":"JI Takanashi","year":"2019","unstructured":"Takanashi, J. I., & Takase, N. (2019). Reader response: Evidence in focus: Nusinersen use in spinal muscular atrophy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology [Comment]. Neurology, 93(10), 464. https:\/\/doi.org\/10.1212\/WNL.0000000000008074","journal-title":"Neurology"},{"issue":"1","key":"162_CR288","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1128\/MCB.00884-09","volume":"30","author":"AY Tan","year":"2010","unstructured":"Tan, A. Y., & Manley, J. L. (2010). TLS inhibits RNA polymerase III transcription [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov\u2019t]. Molecular and Cellular Biology, 30(1), 186\u2013196. https:\/\/doi.org\/10.1128\/MCB.00884-09","journal-title":"Molecular and Cellular Biology"},{"issue":"25","key":"162_CR289","doi-asserted-by":"publisher","first-page":"10559","DOI":"10.1523\/JNEUROSCI.4629-12.2013","volume":"33","author":"TB Tarr","year":"2013","unstructured":"Tarr, T. B., Malick, W., Liang, M., Valdomir, G., Frasso, M., Lacomis, D., Reddel, S. W., Garcia-Ocano, A., Wipf, P., & Meriney, S. D. (2013). Evaluation of a novel calcium channel agonist for therapeutic potential in Lambert-Eaton myasthenic syndrome. Journal of Neuroscience, 33(25), 10559\u201310567.","journal-title":"Journal of Neuroscience"},{"issue":"7628","key":"162_CR290","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature20413","volume":"539","author":"JP Taylor","year":"2016","unstructured":"Taylor, J. P., Brown, R. H., Jr., & Cleveland, D. W. (2016). Decoding ALS: from genes to mechanism [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov\u2019t Review]. Nature, 539(7628), 197\u2013206. https:\/\/doi.org\/10.1038\/nature20413","journal-title":"Nature"},{"issue":"2","key":"162_CR291","doi-asserted-by":"publisher","first-page":"100826","DOI":"10.1016\/j.isci.2020.100826","volume":"23","author":"R Tejero","year":"2020","unstructured":"Tejero, R., Balk, S., Franco-Espin, J., Ojeda, J., Hennlein, L., Drexl, H., Dombert, B., Clausen, J. D., Torres-Benito, L., Saal-Bauernschubert, L., Blum, R., Briese, M., Appenzeller, S., Tabares, L., & Jablonka, S. (2020). R-Roscovitine improves motoneuron function in mouse models for spinal muscular atrophy. iScience, 23(2), 100826. https:\/\/doi.org\/10.1016\/j.isci.2020.100826","journal-title":"iScience"},{"issue":"21","key":"162_CR292","first-page":"4703","volume":"25","author":"R Tejero","year":"2016","unstructured":"Tejero, R., Lopez-Manzaneda, M., Arumugam, S., & Tabares, L. (2016). Synaptotagmin-2, and -1, linked to neurotransmission impairment and vulnerability in Spinal Muscular Atrophy. Human Molecular Genetics, 25(21), 4703\u20134716.","journal-title":"Human Molecular Genetics"},{"issue":"1","key":"162_CR293","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ajhg.2019.05.008","volume":"105","author":"L Torres-Benito","year":"2019","unstructured":"Torres-Benito, L., Schneider, S., Rombo, R., Ling, K. K., Grysko, V., Upadhyay, A., Kononenko, N. L., Rigo, F., Bennett, C. F., & Wirth, B. (2019). NCALD antisense oligonucleotide therapy in addition to nusinersen further ameliorates spinal muscular atrophy in mice. American Journal of Human Genetics, 105(1), 221\u2013230. https:\/\/doi.org\/10.1016\/j.ajhg.2019.05.008","journal-title":"American Journal of Human Genetics"},{"issue":"8","key":"162_CR294","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1038\/mt.2014.84","volume":"22","author":"LK Tsai","year":"2014","unstructured":"Tsai, L. K., Chen, C. L., Ting, C. H., Lin-Chao, S., Hwu, W. L., Dodge, J. C., Passini, M. A., & Cheng, S. H. (2014). Systemic administration of a recombinant AAV1 vector encoding IGF-1 improves disease manifestations in SMA mice. Molecular Therapy, 22(8), 1450\u20131459. https:\/\/doi.org\/10.1038\/mt.2014.84","journal-title":"Molecular Therapy"},{"key":"162_CR295","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.phrs.2016.05.023","volume":"111","author":"YT Tseng","year":"2016","unstructured":"Tseng, Y. T., Chen, C. S., Jong, Y. J., Chang, F. R., & Lo, Y. C. (2016). Loganin possesses neuroprotective properties, restores SMN protein and activates protein synthesis positive regulator Akt\/mTOR in experimental models of spinal muscular atrophy. Pharmacological Research, 111, 58\u201375. https:\/\/doi.org\/10.1016\/j.phrs.2016.05.023","journal-title":"Pharmacological Research"},{"issue":"2","key":"162_CR296","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/emmm.201202303","volume":"5","author":"H Tsuiji","year":"2013","unstructured":"Tsuiji, H., Iguchi, Y., Furuya, A., Kataoka, A., Hatsuta, H., Atsuta, N., Tanaka, F., Hashizume, Y., Akatsu, H., Murayama, S., Sobue, G., & Yamanaka, K. (2013). Spliceosome integrity is defective in the motor neuron diseases ALS and SMA. EMBO Molecular Medicine, 5(2), 221\u2013234.","journal-title":"EMBO Molecular Medicine"},{"key":"162_CR297","doi-asserted-by":"publisher","first-page":"7098","DOI":"10.1038\/ncomms8098","volume":"6","author":"T Udagawa","year":"2015","unstructured":"Udagawa, T., Fujioka, Y., Tanaka, M., Honda, D., Yokoi, S., Riku, Y., Ibi, D., Nagai, T., Yamada, K., Watanabe, H., Katsuno, M., Inada, T., Ohno, K., Sokabe, M., Okado, H., Ishigaki, S., & Sobue, G. (2015). FUS regulates AMPA receptor function and FTLD\/ALS-associated behaviour via GluA1 mRNA stabilization [Research Support, Non-U.S. Gov\u2019t]. Nature Communications, 6, 7098. https:\/\/doi.org\/10.1038\/ncomms8098","journal-title":"Nature Communications"},{"key":"162_CR298","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fnmol.2019.00019","volume":"12","author":"A Upadhyay","year":"2019","unstructured":"Upadhyay, A., Hosseinibarkooie, S., Schneider, S., Kaczmarek, A., Torres-Benito, L., Mendoza-Ferreira, N., Overhoff, M., Rombo, R., Grysko, V., Kye, M. J., Kononenko, N. L., & Wirth, B. (2019). Neurocalcin delta knockout impairs adult neurogenesis whereas half reduction is not pathological. Frontiers in Molecular Neuroscience, 12, 19. https:\/\/doi.org\/10.3389\/fnmol.2019.00019","journal-title":"Frontiers in Molecular Neuroscience"},{"issue":"35","key":"162_CR299","doi-asserted-by":"publisher","first-page":"35ra42","DOI":"10.1126\/scitranslmed.3000830","volume":"2","author":"CF Valori","year":"2010","unstructured":"Valori, C. F., Ning, K., Wyles, M., Mead, R. J., Grierson, A. J., Shaw, P. J., & Azzouz, M. (2010). Systemic delivery of scAAV9 expressing SMN prolongs survival in a model of spinal muscular atrophy. Science Translational Medicine, 2(35), 35ra42. https:\/\/doi.org\/10.1126\/scitranslmed.3000830","journal-title":"Science Translational Medicine"},{"issue":"15\u201316","key":"162_CR300","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1101\/gad.316059.118","volume":"32","author":"M Van Alstyne","year":"2018","unstructured":"Van Alstyne, M., Simon, C. M., Sardi, S. P., Shihabuddin, L. S., Mentis, G. Z., & Pellizzoni, L. (2018). Dysregulation of Mdm2 and Mdm4 alternative splicing underlies motor neuron death in spinal muscular atrophy [Research Support, N.I.H., Extramural Research Support, U.S. Gov\u2019t, Non-P.H.S.]. Genes & Development, 32(15\u201316), 1045\u20131059. https:\/\/doi.org\/10.1101\/gad.316059.118","journal-title":"Genes & Development"},{"key":"162_CR301","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-021-00827-3","author":"M Van Alstyne","year":"2021","unstructured":"Van Alstyne, M., Tattoli, I., Delestree, N., Recinos, Y., Workman, E., Shihabuddin, L. S., Zhang, C., Mentis, G. Z., & Pellizzoni, L. (2021). Gain of toxic function by long-term AAV9-mediated SMN overexpression in the sensorimotor circuit. Nature Neuroscience. https:\/\/doi.org\/10.1038\/s41593-021-00827-3","journal-title":"Nature Neuroscience"},{"issue":"10","key":"162_CR302","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/S1474-4422(13)70210-2","volume":"12","author":"M van Blitterswijk","year":"2013","unstructured":"van Blitterswijk, M., DeJesus-Hernandez, M., Niemantsverdriet, E., Murray, M. E., Heckman, M. G., Diehl, N. N., Brown, P. H., Baker, M. C., Finch, N. A., Bauer, P. O., Serrano, G., Beach, T. G., Josephs, K. A., Knopman, D. S., Petersen, R. C., Boeve, B. F., Graff-Radford, N. R., Boylan, K. B., Petrucelli, L., \u2026 Rademakers, R. (2013). Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study [Comparative Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov\u2019t]. The Lancet Neurology, 12(10), 978\u2013988. https:\/\/doi.org\/10.1016\/S1474-4422(13)70210-2","journal-title":"The Lancet Neurology"},{"issue":"5","key":"162_CR303","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1212\/WNL.0b013e3181ccc732","volume":"74","author":"T Van Langenhove","year":"2010","unstructured":"Van Langenhove, T., van der Zee, J., Sleegers, K., Engelborghs, S., Vandenberghe, R., Gijselinck, I., Van den Broeck, M., Mattheijssens, M., Peeters, K., De Deyn, P. P., Cruts, M., & Van Broeckhoven, C. (2010). Genetic contribution of FUS to frontotemporal lobar degeneration [Research Support, Non-U.S. Gov\u2019t]. Neurology, 74(5), 366\u2013371. https:\/\/doi.org\/10.1212\/WNL.0b013e3181ccc732","journal-title":"Neurology"},{"issue":"5918","key":"162_CR304","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1126\/science.1165942","volume":"323","author":"C Vance","year":"2009","unstructured":"Vance, C., Rogelj, B., Hortobagyi, T., De Vos, K. J., Nishimura, A. L., Sreedharan, J., Hu, X., Smith, B., Ruddy, D., Wright, P., Ganesalingam, J., Williams, K. L., Tripathi, V., Al-Saraj, S., Al-Chalabi, A., Leigh, P. N., Blair, I. P., Nicholson, G., de Belleroche, J., \u2026 Shaw, C. E. (2009). Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6 [Research Support, Non-U.S. Gov\u2019t]. Science, 323(5918), 1208\u20131211. https:\/\/doi.org\/10.1126\/science.1165942","journal-title":"Science"},{"issue":"1","key":"162_CR305","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13023-017-0671-8","volume":"12","author":"IEC Verhaart","year":"2017","unstructured":"Verhaart, I. E. C., Robertson, A., Wilson, I. J., Aartsma-Rus, A., Cameron, S., Jones, C. C., Cook, S. F., & Lochmuller, H. (2017). Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy\u2014A literature review. Orphanet Journal of Rare Diseases, 12(1), 124. https:\/\/doi.org\/10.1186\/s13023-017-0671-8","journal-title":"Orphanet Journal of Rare Diseases"},{"issue":"7","key":"162_CR306","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41582-019-0203-3","volume":"15","author":"IEC Verhaart","year":"2019","unstructured":"Verhaart, I. E. C., & Aartsma-Rus, A. (2019). Therapeutic developments for Duchenne muscular dystrophy. Nature Reviews Neurology, 15(7), 373\u2013386. https:\/\/doi.org\/10.1038\/s41582-019-0203-3","journal-title":"Nature Reviews Neurology"},{"issue":"4","key":"162_CR307","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1093\/hmg\/ddx434","volume":"27","author":"E Villalon","year":"2018","unstructured":"Villalon, E., Shababi, M., Kline, R., Lorson, Z. C., Florea, K. M., & Lorson, C. L. (2018). Selective vulnerability in neuronal populations in nmd\/SMARD1 mice. Human Molecular Genetics, 27(4), 679\u2013690. https:\/\/doi.org\/10.1093\/hmg\/ddx434","journal-title":"Human Molecular Genetics"},{"issue":"5","key":"162_CR308","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.nmd.2018.03.007","volume":"28","author":"G Vrbova","year":"2018","unstructured":"Vrbova, G., & Slawinska, U. (2018). Critical period of neuromuscular development: Importance for a new treatment of SMA. Neuromuscular Disorders, 28(5), 385\u2013393. https:\/\/doi.org\/10.1016\/j.nmd.2018.03.007","journal-title":"Neuromuscular Disorders"},{"issue":"11","key":"162_CR309","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0167087","volume":"11","author":"RI Wadman","year":"2016","unstructured":"Wadman, R. I., Stam, M., Jansen, M. D., van der Weegen, Y., Wijngaarde, C. A., Harschnitz, O., Sodaar, P., Braun, K. P., Dooijes, D., Lemmink, H. H., van den Berg, L. H., & van der Pol, W. L. (2016). A comparative study of SMN protein and mRNA in blood and fibroblasts in patients with spinal muscular atrophy and healthy controls [Clinical Trial Comparative Study]. PLoS ONE, 11(11), e0167087. https:\/\/doi.org\/10.1371\/journal.pone.0167087","journal-title":"PLoS ONE"},{"issue":"20","key":"162_CR310","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1212\/WNL.0b013e3182749eca","volume":"79","author":"RI Wadman","year":"2012","unstructured":"Wadman, R. I., Vrancken, A. F., van den Berg, L. H., & van der Pol, W. L. (2012). Dysfunction of the neuromuscular junction in spinal muscular atrophy types 2 and 3. Neurology, 79(20), 2050\u20132055. https:\/\/doi.org\/10.1212\/WNL.0b013e3182749eca","journal-title":"Neurology"},{"issue":"21","key":"162_CR311","doi-asserted-by":"publisher","first-page":"3399","DOI":"10.1093\/hmg\/ddn234","volume":"17","author":"MP Walker","year":"2008","unstructured":"Walker, M. P., Rajendra, T. K., Saieva, L., Fuentes, J. L., Pellizzoni, L., & Matera, A. G. (2008). SMN complex localizes to the sarcomeric Z-disc and is a proteolytic target of calpain. Human Molecular Genetics, 17(21), 3399\u20133410. https:\/\/doi.org\/10.1093\/hmg\/ddn234","journal-title":"Human Molecular Genetics"},{"issue":"5","key":"162_CR312","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","volume":"18","author":"D Wang","year":"2019","unstructured":"Wang, D., Tai, P. W. L., & Gao, G. (2019). Adeno-associated virus vector as a platform for gene therapy delivery. Nature Reviews Drug Discovery, 18(5), 358\u2013378. https:\/\/doi.org\/10.1038\/s41573-019-0012-9","journal-title":"Nature Reviews Drug Discovery"},{"issue":"7200","key":"162_CR313","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/nature06992","volume":"454","author":"X Wang","year":"2008","unstructured":"Wang, X., Arai, S., Song, X., Reichart, D., Du, K., Pascual, G., Tempst, P., Rosenfeld, M. G., Glass, C. K., & Kurokawa, R. (2008). Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription [Research Support, N.I.H., Extramural]. Nature, 454(7200), 126\u2013130. https:\/\/doi.org\/10.1038\/nature06992","journal-title":"Nature"},{"issue":"3","key":"162_CR314","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s00247-017-4031-6","volume":"48","author":"JJ Weaver","year":"2018","unstructured":"Weaver, J. J., Natarajan, N., Shaw, D. W. W., Apkon, S. D., Koo, K. S. H., Shivaram, G. M., & Monroe, E. J. (2018). Transforaminal intrathecal delivery of nusinersen using cone-beam computed tomography for children with spinal muscular atrophy and extensive surgical instrumentation: Early results of technical success and safety. Pediatric Radiology, 48(3), 392\u2013397. https:\/\/doi.org\/10.1007\/s00247-017-4031-6","journal-title":"Pediatric Radiology"},{"issue":"6","key":"162_CR315","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.neuron.2014.12.010","volume":"84","author":"X Wen","year":"2014","unstructured":"Wen, X., Tan, W., Westergard, T., Krishnamurthy, K., Markandaiah, S. S., Shi, Y., Lin, S., Shneider, N. A., Monaghan, J., Pandey, U. B., Pasinelli, P., Ichida, J. K., & Trotti, D. (2014). Antisense proline-arginine RAN dipeptides linked to C9ORF72-ALS\/FTD form toxic nuclear aggregates that initiate in vitro and in vivo neuronal death [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov\u2019t]. Neuron, 84(6), 1213\u20131225. https:\/\/doi.org\/10.1016\/j.neuron.2014.12.010","journal-title":"Neuron"},{"key":"162_CR316","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/BF01776636","volume":"22","author":"G Werdnig","year":"1891","unstructured":"Werdnig, G. (1891). Zwei fr\u00fchinfantile heredit\u00e4re F\u00e4lle von progressiver Muskelatrophie unter dem Bilde der Dystrophie, aber auf neurotischer Grundlage. Archiv f\u00fcr Psychiatrie und Nervenkrankheiten, 22, 437.","journal-title":"Archiv f\u00fcr Psychiatrie und Nervenkrankheiten"},{"issue":"19","key":"162_CR317","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1101\/gad.342005","volume":"19","author":"C Winkler","year":"2005","unstructured":"Winkler, C., Eggert, C., Gradl, D., Meister, G., Giegerich, M., Wedlich, D., Laggerbauer, B., & Fischer, U. (2005). Reduced U snRNP assembly causes motor axon degeneration in an animal model for spinal muscular atrophy. Genes & Development, 19(19), 2320\u20132330.","journal-title":"Genes & Development"},{"issue":"3","key":"162_CR318","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9","volume":"15","author":"B Wirth","year":"2000","unstructured":"Wirth, B. (2000). An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA). Human Mutation, 15(3), 228\u2013237.","journal-title":"Human Mutation"},{"issue":"4","key":"162_CR319","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s00439-006-0156-7","volume":"119","author":"B Wirth","year":"2006","unstructured":"Wirth, B., Brichta, L., Schrank, B., Lochmuller, H., Blick, S., Baasner, A., & Heller, R. (2006). Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number. Human Genetics, 119(4), 422\u2013428. (IN FILE).","journal-title":"Human Genetics"},{"issue":"5","key":"162_CR320","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1086\/302369","volume":"64","author":"B Wirth","year":"1999","unstructured":"Wirth, B., Herz, M., Wetter, A., Moskau, S., Hahnen, E., Rudnik-Schoneborn, S., Wienker, T., & Zerres, K. (1999). Quantitative analysis of survival motor neuron copies: Identification of subtle SMN1 mutations in patients with spinal muscular atrophy, genotype-phenotype correlation, and implications for genetic counseling. American Journal of Human Genetics, 64(5), 1340\u20131356.","journal-title":"American Journal of Human Genetics"},{"key":"162_CR321","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-genom-102319-103602","author":"B Wirth","year":"2020","unstructured":"Wirth, B., Karakaya, M., Kye, M. J., & Mendoza-Ferreira, N. (2020). Twenty-five years of spinal muscular atrophy research: From phenotype to genotype to therapy, and what comes next. Annual Review of Genomics and Human Genetics. https:\/\/doi.org\/10.1146\/annurev-genom-102319-103602","journal-title":"Annual Review of Genomics and Human Genetics"},{"key":"162_CR322","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/j.1460-9568.1993.tb00513.x","volume":"5","author":"V Wong","year":"1993","unstructured":"Wong, V., Arriga, R., Ip, N., & Lindsay, R. M. (1993). The neurotrophins BDNF, NT-3 and NT-4\/5, but not NGF, upregulate the cholinergic phenotype of developing motoneurons. European Journal of Neuroscience, 5, 466\u2013474. (IN FILE).","journal-title":"European Journal of Neuroscience"},{"issue":"4","key":"162_CR323","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.celrep.2012.08.025","volume":"2","author":"T Yamazaki","year":"2012","unstructured":"Yamazaki, T., Chen, S., Yu, Y., Yan, B., Haertlein, T. C., Carrasco, M. A., Tapia, J. C., Zhai, B., Das, R., Lalancette-Hebert, M., Sharma, A., Chandran, S., Sullivan, G., Nishimura, A. L., Shaw, C. E., Gygi, S. P., Shneider, N. A., Maniatis, T., & Reed, R. (2012). FUS-SMN protein interactions link the motor neuron diseases ALS and SMA. Cell Reports, 2(4), 799\u2013806.","journal-title":"Cell Reports"},{"issue":"Pt 3","key":"162_CR324","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1113\/jphysiol.2001.013376","volume":"540","author":"Z Yan","year":"2002","unstructured":"Yan, Z., Chi, P., Bibb, J. A., Ryan, T. A., & Greengard, P. (2002). Roscovitine: A novel regulator of P\/Q-type calcium channels and transmitter release in central neurons. Journal of Physiology, 540(Pt 3), 761\u2013770.","journal-title":"Journal of Physiology"},{"issue":"4","key":"162_CR325","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1083\/jcb.201608022","volume":"216","author":"K Yasuda","year":"2017","unstructured":"Yasuda, K., Clatterbuck-Soper, S. F., Jackrel, M. E., Shorter, J., & Mili, S. (2017). FUS inclusions disrupt RNA localization by sequestering kinesin-1 and inhibiting microtubule detyrosination. Journal of Cell Biology, 216(4), 1015\u20131034. https:\/\/doi.org\/10.1083\/jcb.201608022","journal-title":"Journal of Cell Biology"},{"issue":"5","key":"162_CR326","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/wrna.1352","volume":"7","author":"K Yasuda","year":"2016","unstructured":"Yasuda, K., & Mili, S. (2016). Dysregulated axonal RNA translation in amyotrophic lateral sclerosis. Wiley Interdisciplinary Reviews: RNA, 7(5), 589\u2013603. https:\/\/doi.org\/10.1002\/wrna.1352","journal-title":"Wiley Interdisciplinary Reviews: RNA"},{"issue":"13","key":"162_CR327","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1016\/j.celrep.2017.08.100","volume":"20","author":"S Yokoi","year":"2017","unstructured":"Yokoi, S., Udagawa, T., Fujioka, Y., Honda, D., Okado, H., Watanabe, H., Katsuno, M., Ishigaki, S., & Sobue, G. (2017). 3\u2019UTR length-dependent control of SynGAP Isoform alpha2 mRNA by FUS and ELAV-like proteins promotes dendritic spine maturation and cognitive function. Cell Reports, 20(13), 3071\u20133084. https:\/\/doi.org\/10.1016\/j.celrep.2017.08.100","journal-title":"Cell Reports"},{"issue":"4","key":"162_CR328","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.mcn.2009.04.013","volume":"41","author":"JH Yoon","year":"2009","unstructured":"Yoon, J. H., Chandrasekharan, K., Xu, R., Glass, M., Singhal, N., & Martin, P. T. (2009). The synaptic CT carbohydrate modulates binding and expression of extracellular matrix proteins in skeletal muscle: Partial dependence on utrophin [Research Support, N.I.H., Extramural]. Molecular and Cellular Neuroscience, 41(4), 448\u2013463. https:\/\/doi.org\/10.1016\/j.mcn.2009.04.013","journal-title":"Molecular and Cellular Neuroscience"},{"issue":"7","key":"162_CR329","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1136\/jnnp-2012-303144","volume":"84","author":"Y Yoshiyama","year":"2013","unstructured":"Yoshiyama, Y., Lee, V. M., & Trojanowski, J. Q. (2013). Therapeutic strategies for tau mediated neurodegeneration [Research Support, Non-U.S. Gov\u2019t Review]. Journal of Neurology, Neurosurgery & Psychiatry, 84(7), 784\u2013795. https:\/\/doi.org\/10.1136\/jnnp-2012-303144","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"3","key":"162_CR330","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1371\/journal.pone.0150640","volume":"11","author":"P Zaworski","year":"2016","unstructured":"Zaworski, P., von Herrmann, K. M., Taylor, S., Sunshine, S. S., McCarthy, K., Risher, N., Newcomb, T., Weetall, M., Prior, T. W., Swoboda, K. J., Chen, K. S., & Paushkin, S. (2016). SMN protein can be reliably measured in whole blood with an Electrochemiluminescence (ECL) immunoassay: Implications for clinical trials [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov\u2019t]. PLoS ONE, 11(3), 640. https:\/\/doi.org\/10.1371\/journal.pone.0150640","journal-title":"PLoS ONE"},{"issue":"3","key":"162_CR331","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/jcsm.12542","volume":"11","author":"H Zhou","year":"2020","unstructured":"Zhou, H., Meng, J., Malerba, A., Catapano, F., Sintusek, P., Jarmin, S., Feng, L., Lu-Nguyen, N., Sun, L., Mariot, V., Dumonceaux, J., Morgan, J. E., Gissen, P., Dickson, G., & Muntoni, F. (2020). Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy. Journal of Cachexia, Sarcopenia and Muscle, 11(3), 768\u2013782. https:\/\/doi.org\/10.1002\/jcsm.12542","journal-title":"Journal of Cachexia, Sarcopenia and Muscle"},{"issue":"1","key":"162_CR332","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/s0014-5793(00)01570-2","volume":"474","author":"X Zhu","year":"2000","unstructured":"Zhu, X., Hadhazy, M., Wehling, M., Tidball, J. G., & McNally, E. M. (2000). Dominant negative myostatin produces hypertrophy without hyperplasia in muscle. FEBS Letters, 474(1), 71\u201375. https:\/\/doi.org\/10.1016\/s0014-5793(00)01570-2","journal-title":"FEBS Letters"},{"issue":"Pt 15","key":"162_CR333","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1242\/jcs.110.15.1741","volume":"110","author":"H Zinszner","year":"1997","unstructured":"Zinszner, H., Sok, J., Immanuel, D., Yin, Y., & Ron, D. (1997). TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling [Research Support, Non-U.S. Gov\u2019t Research Support, U.S. Gov\u2019t, P.H.S.]. Journal of Cell Science, 110(Pt 15), 1741\u20131750.","journal-title":"Journal of Cell Science"},{"issue":"7","key":"162_CR334","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1136\/jnnp-2016-315018","volume":"88","author":"ZY Zou","year":"2017","unstructured":"Zou, Z. Y., Zhou, Z. R., Che, C. H., Liu, C. Y., He, R. L., & Huang, H. P. (2017). Genetic epidemiology of amyotrophic lateral sclerosis: A systematic review and meta-analysis [Meta-Analysis Review Systematic Review]. Journal of Neurology, Neurosurgery and Psychiatry, 88(7), 540\u2013549. https:\/\/doi.org\/10.1136\/jnnp-2016-315018","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"51","key":"162_CR335","doi-asserted-by":"publisher","first-page":"E4968","DOI":"10.1073\/pnas.1315438110","volume":"110","author":"T Zu","year":"2013","unstructured":"Zu, T., Liu, Y., Banez-Coronel, M., Reid, T., Pletnikova, O., Lewis, J., Miller, T. M., Harms, M. B., Falchook, A. E., Subramony, S. H., Ostrow, L. W., Rothstein, J. D., Troncoso, J. C., & Ranum, L. P. (2013). RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia [Clinical Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov\u2019t]. Proceedings of the National Academy of Sciences USA, 110(51), E4968-4977. https:\/\/doi.org\/10.1073\/pnas.1315438110","journal-title":"Proceedings of the National Academy of Sciences USA"}],"container-title":["Neurological Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42466-021-00162-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42466-021-00162-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42466-021-00162-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T13:42:22Z","timestamp":1726407742000},"score":1,"resource":{"primary":{"URL":"https:\/\/neurolrespract.biomedcentral.com\/articles\/10.1186\/s42466-021-00162-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,4]]},"references-count":335,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["162"],"URL":"https:\/\/doi.org\/10.1186\/s42466-021-00162-9","relation":{},"ISSN":["2524-3489"],"issn-type":[{"value":"2524-3489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,4]]},"assertion":[{"value":"20 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2"}}